PFE


Line plots across dimensions of each concept
Tables

Table of contents



us-gaap:CommonStockValue
us-gaap:StatementEquityComponents
us-gaap:SharesIssued

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic

us-gaap:EarningsPerShareBasic

us-gaap:EarningsPerShareDiluted

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ConsolidationItems
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
us-gaap:Currency, us-gaap:StatementGeographical
us-gaap:ProductOrService, us-gaap:ReportingUnit, us-gaap:StatementBusinessSegments
us-gaap:ProductOrService, us-gaap:StatementBusinessSegments
us-gaap:ReportingUnit, us-gaap:StatementBusinessSegments
us-gaap:StatementBusinessSegments
us-gaap:StatementGeographical

us-gaap:CostOfGoodsAndServicesSold

us-gaap:SellingGeneralAndAdministrativeExpense

us-gaap:InterestExpense

us-gaap:OtherNonoperatingIncomeExpense
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

us-gaap:IncomeLossFromContinuingOperations

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
us-gaap:ConsolidationItems
us-gaap:ConsolidationItems, pfe:OtherSegmentReconcilingItems
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest

us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity

us-gaap:IncomeTaxExpenseBenefit

us-gaap:IncomeTaxesPaidNet

us-gaap:ProfitLoss
us-gaap:StatementEquityComponents

us-gaap:ComprehensiveIncomeNetOfTax

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest

us-gaap:NetIncomeLoss

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest

us-gaap:Assets
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementFrequency

us-gaap:Liabilities

us-gaap:LiabilitiesAndStockholdersEquity

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:AssetsCurrent

us-gaap:CashAndCashEquivalentsAtCarryingValue

us-gaap:ShortTermInvestments

us-gaap:AccountsReceivableNetCurrent

us-gaap:InventoryNet

us-gaap:OtherAssetsCurrent

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment

us-gaap:PropertyPlantAndEquipmentNet

us-gaap:LongTermInvestments

us-gaap:Goodwill
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:IntangibleAssetsNetExcludingGoodwill

us-gaap:FiniteLivedIntangibleAssetsNet
us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:OtherAssetsNoncurrent
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency

us-gaap:LiabilitiesCurrent

us-gaap:DebtCurrent

us-gaap:LongTermDebtCurrent
us-gaap:LongtermDebtType

us-gaap:AccountsPayableCurrent

us-gaap:TaxesPayableCurrent

us-gaap:OtherLiabilitiesCurrent

us-gaap:DividendsPayableCurrent
us-gaap:DebtInstrument, us-gaap:LongtermDebtType
us-gaap:LongTermDebt
us-gaap:DerivativeInstrumentRisk
us-gaap:LongtermDebtType

us-gaap:LongTermDebtNoncurrent
us-gaap:LongtermDebtType

us-gaap:MinorityInterest

us-gaap:OtherLiabilitiesNoncurrent

us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
us-gaap:StatementEquityComponents

us-gaap:CommonStockValue

us-gaap:AdditionalPaidInCapital

us-gaap:RetainedEarningsAccumulatedDeficit

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax

us-gaap:TreasuryStockValue

us-gaap:MinorityInterest

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:NetCashProvidedByUsedInOperatingActivities

us-gaap:NetIncomeLoss

us-gaap:ProfitLoss
us-gaap:StatementEquityComponents

us-gaap:NetCashProvidedByUsedInInvestingActivities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

us-gaap:NetCashProvidedByUsedInFinancingActivities

us-gaap:ProceedsFromIssuanceOfLongTermDebt

us-gaap:RepaymentsOfLongTermDebt

us-gaap:PaymentsForRepurchaseOfCommonStock

us-gaap:RepaymentsOfLongTermDebt

us-gaap:EffectiveIncomeTaxRateContinuingOperations

us-gaap:ShareBasedCompensation

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

pfe:AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction

pfe:AssetWriteOffsAndAssetImpairmentCharges

pfe:BusinessAlignmentCosts

pfe:BusinessCombinationAcquisitionRelatedCostsTransactionCosts

pfe:DeconsolidationGainLossAmountNetOfCashConveyed

pfe:DefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeLossNetActuarialGainLossTax

pfe:DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization

pfe:ImplementationCosts
us-gaap:IncomeStatementLocation

pfe:IncomeLossFromCollaborationsLicensingAgreementsAndSalesOfCompoundProductRights

pfe:IncomeLossFromContinuingOperationsAvailableToCommonStockholdersBasic

pfe:IncomeLossFromContinuingOperationsAvailableToCommonStockholdersdiluted

pfe:IncomeLossFromEquityMethodInvestmentsNetExcessBasisAmortization

pfe:InterestPaidInterestRateHedges
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
pfe:OtherComprehensiveIncomeLossNonDerivativeNetInvestmentHedgeGainLossbeforeReclassificationandTax
us-gaap:IncomeStatementLocation
pfe:OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossReclassificationBeforeTax

pfe:OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossbeforeReclassificationandTax
us-gaap:IncomeStatementLocation
pfe:OtherComprehensiveIncomeLossNonDerivativesAndDerivativesOtherGainLossReclassificationBeforeTax

pfe:OtherComprehensiveIncomeLossNonDerivativesAndDerivativesOtherGainLossbeforeReclassificationandTax

pfe:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodTax

pfe:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax

pfe:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetUnamortizedGainLossArisingDuringPeriodTax

pfe:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetUnamortizedGainLossArisingDuringPeriodbeforeTax

pfe:OtherComprehensiveIncomeLossSettlementAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansforNetGainLossBeforeTax

pfe:OtherComprehensiveIncomeLossSettlementAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansforNetGainLossTax

pfe:OtherNonoperatingIncomeExpenseNet

pfe:PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess

pfe:PaymentsforRestructuringOtherRestructuringAndRestructuringTranslationAdjustment
us-gaap:RestructuringCostAndReserve

pfe:PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense

pfe:PercentageChangeInRevenue
us-gaap:StatementGeographical

pfe:RestructuringAssetImpairmentCharges

pfe:RestructuringChargesAcquisitionRelatedCostsandImplementationCosts

pfe:RestructuringChargesAndAcquisitionRelatedCosts
us-gaap:StatementEquityComponents
pfe:StockIssuedAndRedeemedDuringPeriodSharesConversionAndRedemptionofStock
us-gaap:StatementEquityComponents
pfe:StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:AmortizationOfIntangibleAssets
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:AssetImpairmentCharges

us-gaap:BusinessCombinationIntegrationRelatedCosts

us-gaap:BusinessExitCosts1

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation
us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation
us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1

us-gaap:DeconsolidationGainOrLossAmount

us-gaap:DeferredIncomeTaxExpenseBenefit
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax

us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanContributionsByEmployer
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanInterestCost
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:IncomeStatementLocation
us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanServiceCost
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanSpecialTerminationBenefits
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType
us-gaap:IncomeStatementLocation
us-gaap:DerivativeGainLossOnDerivativeNet
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation
us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

us-gaap:DividendsCommonStockCash
us-gaap:StatementEquityComponents

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents

us-gaap:EquitySecuritiesFvNiGainLoss

us-gaap:EquitySecuritiesFvNiRealizedGainLoss

us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName
us-gaap:LitigationCase, us-gaap:ProductOrService, us-gaap:LitigationStatus
us-gaap:GainContingencyPatentsFoundNotInfringedUponNumber

us-gaap:GainLossOnDispositionOfAssets1

us-gaap:GainLossRelatedToLitigationSettlement

us-gaap:GainsLossesOnExtinguishmentOfDebt

us-gaap:GoodwillOtherIncreaseDecrease
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill
us-gaap:ConsolidationItems, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:StatementBusinessSegments
us-gaap:ProductOrService, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass, us-gaap:Subsegments

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare

us-gaap:IncreaseDecreaseInOperatingCapital

us-gaap:InterestPaidNet

us-gaap:InterestRevenueExpenseNet
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName
us-gaap:InvestmentIncomeDividend

us-gaap:InvestmentIncomeInterest

us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders

us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent

us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax

us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax

us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax

us-gaap:OtherComprehensiveIncomeLossBeforeTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation
us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax
us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation
us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax

us-gaap:OtherComprehensiveIncomeLossNetOfTax
us-gaap:StatementEquityComponents
us-gaap:StatementEquityComponents
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax

us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax

us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax

us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax

us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax

us-gaap:OtherComprehensiveIncomeLossTax

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax

us-gaap:OtherNoncashIncomeExpense

us-gaap:PaymentsForProceedsFromOtherInvestingActivities

us-gaap:PaymentsOfOrdinaryDividends

us-gaap:PaymentsToAcquireIntangibleAssets

us-gaap:PaymentsToAcquireMarketableSecurities

us-gaap:PaymentsToAcquireShortTermInvestments

us-gaap:PreferredStockDividendsIncomeStatementImpact

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities

us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess

us-gaap:ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments

us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments

us-gaap:ProceedsFromShortTermDebt

us-gaap:ProceedsFromStockOptionsExercised

us-gaap:RepaymentsOfShortTermDebt

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:RestructuringPlan
us-gaap:RestructuringAndRelatedCostIncurredCost

us-gaap:RestructuringCharges
us-gaap:ConsolidationItems
us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments
us-gaap:RestructuringCostAndReserve

us-gaap:RestructuringReserveAcceleratedDepreciation
us-gaap:IncomeStatementLocation

us-gaap:RoyaltyIncomeNonoperating

us-gaap:SeveranceCosts1
us-gaap:StatementEquityComponents
us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
us-gaap:StatementEquityComponents

us-gaap:StockholdersEquityOther
us-gaap:StatementEquityComponents

us-gaap:TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit
us-gaap:StatementEquityComponents
us-gaap:TreasuryStockSharesAcquired

us-gaap:TreasuryStockValueAcquiredCostMethod
us-gaap:StatementEquityComponents

us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
us-gaap:BalanceSheetLocation
pfe:AccruedRebates
us-gaap:FinancialInstrument
pfe:AvailableforsaleSecuritiesDebtMaturitiesAfterYearFiveFairValue

pfe:DebtInstrumentFairValueAdjustmentsHedgingandPurchaseAccounting
us-gaap:LongtermDebtType

pfe:DebtSecuritiesAccumulatedGrossUnrealizedGain

pfe:DebtSecuritiesAccumulatedGrossUnrealizedLoss

pfe:DebtSecuritiesAmortizedCostBasis

pfe:DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent

pfe:EquitySecuritiesFVNINoncurrent
us-gaap:FairValueByMeasurementFrequency
pfe:EquitySecuritiesFVNIRestrictedNoncurrent

pfe:HeldToMaturityCashEquivalents
us-gaap:FinancialInstrument
pfe:HeldtomaturitySecuritiesDebtMaturitiesAfterYearFiveFairValue
us-gaap:ConsolidationItems, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:StatementBusinessSegments
pfe:IntangibleAssetsNetPercentageofIntangibleAssetsNet
us-gaap:ConsolidationItems, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:Subsegments
us-gaap:ConsolidationItems, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass, us-gaap:StatementBusinessSegments
us-gaap:ConsolidationItems, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass, us-gaap:Subsegments

pfe:LongtermDebtCurrentMaturitiesExcludingNetFairValueAdjustmentsRelatedToHedgingAndPurchaseAccounting
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
pfe:LongtermInvestmentsExcludingHeldToMaturitySecuritiesAndPrivateEquityInvestments
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation
pfe:OtherAccruals

pfe:OtherTaxAssetsCurrent

pfe:PrivateEquityInvestments

pfe:RebatesAndDiscountsAccrual
us-gaap:BalanceSheetLocation

pfe:ShorttermDebtGross
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
pfe:ShorttermInvestmentsExcludingHeldToMaturitySecurities
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
us-gaap:FinancialInstrument
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
us-gaap:FinancialInstrument
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
us-gaap:FinancialInstrument
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
us-gaap:FinancialInstrument
us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent

us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent

us-gaap:BusinessCombinationContingentConsiderationLiability

us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent

us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent

us-gaap:CommercialPaper
us-gaap:LongtermDebtType
us-gaap:DebtInstrumentCarryingAmount

us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
us-gaap:LongtermDebtType

us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturity

us-gaap:DeferredIncomeTaxLiabilitiesNet

us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType
us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType
us-gaap:RetirementPlanType

us-gaap:DerivativeAssets
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:HedgingDesignation
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:DerivativeAssetsCurrent
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:DerivativeAssetsNoncurrent
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency

us-gaap:DerivativeLiabilities
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByMeasurementFrequency
us-gaap:HedgingDesignation
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:DerivativeLiabilitiesCurrent
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:DerivativeLiabilitiesNoncurrent
us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation
us-gaap:DerivativeNotionalAmount
us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, pfe:HedgedItem

us-gaap:EmployeeRelatedLiabilitiesCurrent

us-gaap:EquityMethodInvestments
us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName

us-gaap:EquitySecuritiesFvNi
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency, us-gaap:FinancialInstrument

us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:FiniteLivedIntangibleAssetsGross
us-gaap:FiniteLivedIntangibleAssetsByMajorClass
us-gaap:BalanceSheetLocation
us-gaap:HedgedAssetFairValueHedgeCumulativeIncreaseDecrease
us-gaap:BalanceSheetLocation
us-gaap:HedgedLiabilityDiscontinuedFairValueHedgeCumulativeIncreaseDecrease
us-gaap:BalanceSheetLocation
us-gaap:HedgedLiabilityFairValueHedge
us-gaap:BalanceSheetLocation
us-gaap:HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease
us-gaap:FinancialInstrument
us-gaap:HeldToMaturitySecurities

us-gaap:HeldToMaturitySecuritiesCurrent
us-gaap:FinancialInstrument
us-gaap:HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
us-gaap:FinancialInstrument
us-gaap:HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue
us-gaap:FinancialInstrument
us-gaap:HeldToMaturitySecuritiesFairValue

us-gaap:HeldToMaturitySecuritiesNoncurrent

us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass

us-gaap:IntangibleAssetsGrossExcludingGoodwill

us-gaap:InventoryFinishedGoodsNetOfReserves

us-gaap:InventoryNoncurrent

us-gaap:InventoryRawMaterialsAndSuppliesNetOfReserves

us-gaap:InventoryWorkInProcessNetOfReserves

us-gaap:LiabilityForUncertainTaxPositionsNoncurrent
us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency
us-gaap:LifeSettlementContractsFairValueMethodCarryingAmount
us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementBasis
us-gaap:LongTermDebtFairValue
us-gaap:FairValueByMeasurementBasis
us-gaap:Ownership, us-gaap:StatementScenario
us-gaap:MinorityInterestOwnershipPercentageByParent
us-gaap:LongtermDebtType
us-gaap:OtherLongTermDebt

us-gaap:OtherLongTermInvestments

us-gaap:OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent

us-gaap:OtherShortTermBorrowings

us-gaap:PreferredStockValue

us-gaap:RestructuringReserve
us-gaap:BalanceSheetLocation
us-gaap:RestructuringCostAndReserve
us-gaap:BalanceSheetLocation
us-gaap:TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability

Tables

  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:CommonStockValue █▇▇▇▇▇▇▇▇▆▆▆▆▆▆▆▅▅▅▅▅▄▄▄▄▃▃▃▃▂▂▂▁▁▁▁▁470468468468468467466465465464463463463461461461460459459458458455455454454453452451450447447446445445445445444NANANA
 us-gaap:SharesIssued us-gaap:StatementEquityComponents us-gaap:CommonStock█▇▆▆▆▄▄▃▂▁9393936993669363935893329326930392999275NANANA9230NANANA9178NANANA9110NANANA9051NANANANANANA8902NANANANANANANA
 us-gaap:SharesIssued us-gaap:StatementEquityComponents us-gaap:PreferredStock▄▄▄▄▄▄▄▄▄▄0000000000NANANA0NANANA0NANANA717NANANA0NANANANANANA0NANANANANANANA
 us-gaap:SharesIssued us-gaap:StatementEquityComponents us-gaap:TreasuryStock██▁▁██▁▁██38413835-3835-380138013615-3484-343834373296NANANA3160NANANA3003NANANA-2819NANANA2652NANANANANANA-1327NANANANANANANA
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding 5613NA564956725750NA598659526057NA604160376092NA613861376214NA624362436292NA640364446476NA665671177269750875377598NA7810793579358035805780728101
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic 5545NA554555625635NA587558665957NA595159586006NA606660686150NA616861596203NA633063686389NA658170427187743674767537NA7770787578757982802780468061
us-gaap:EarningsPerShareBasic ▃▁▆▄▃▁▄▃▃█▃▃▃▂▂▂▃▁▂▃▂▂▃▃▂0.61-0.060000000000000051.380.910.69-0.060000000000000050.70.660.62.05999999999999960.480.520.520.13999999999999990.220.330.49-0.0200000000000000180.350.430.380.199999999999999960.420.460.36NA0.392.00.380.430.440.240.189999999999999950.480.330.330.280.110.310.25
us-gaap:EarningsPerShareDiluted ▃▁▆▄▃▁▃▃▃█▃▃▃▂▂▂▃▁▂▃▂▂▃▃▂0.61-0.049999999999999821.360.890.68-0.049999999999999820.690.650.592.03000000000000020.470.510.510.13999999999999990.210.330.49-0.0299999999999998050.340.420.380.189999999999999950.420.450.36NA0.391.980.380.430.430.240.189999999999999950.480.330.330.280.110.310.25
us-gaap:IncomeLossFromContinuingOperationsPerBasicShare ▃▁▆▄▃▁▄▃▃█▃▃▃▂▂▂▃▁▂▃▂▂▃▃▂0.61-0.060000000000000051.380.910.69-0.060000000000000050.70.660.62.05999999999999960.480.520.520.13999999999999990.220.330.49-0.0200000000000000180.340.430.380.199999999999999960.420.460.35NA0.390.510.380.420.430.240.190000000000000060.310.330.330.280.110.30.25
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare ▃▁▆▄▃▁▄▃▃█▃▃▃▂▂▂▃▁▂▃▂▂▃▃▂0.61-0.049999999999999821.360.890.68-0.059999999999999830.690.650.592.03000000000000020.470.510.510.13999999999999990.220.330.49-0.0299999999999998050.340.420.380.189999999999999950.420.450.35NA0.390.50.380.410.420.240.200000000000000070.310.330.330.280.110.30.25
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax ▂▃▃▄▃▄▄▄▃▄▄▃▃▄▃▄▃▅▂▂▁▃▃▃▂▄▃▃▄▄▆▆████▇▇█▇12028126881268013264131181397713298134661290613703131681289612779136281304513147130051404712087118531086413118123611277311353135581264312973135001397615057154051674617193169841698416502159951713216576
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems us-gaap:OperatingSegments▁▃▂▂▂█▆▆▁▇▅▄120281268912303124021225913977132981346612001137031316812896NANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,pfe:BiopharmaSegment▆█▆▄▂▅▃▃▁100071053210108959591859821942294348881NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,pfe:UpjohnSegment▁▂▂▆▇█▇██202221562195280730753182303631473120NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Currency,us-gaap:StatementGeographical currency:EUR,pfe:DevelopedEurope▁▃▂▃▂▄▃▄▂▃▂▂▂▄▂▄▃▄▃▃▃▇▆▇▆█▅▆▅15001800170018001700200018001900170018001700170016001900170019001800200018001800180024002200230022002500210022002100NANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService,us-gaap:ReportingUnit,us-gaap:StatementBusinessSegments pfe:Eliquis,pfe:InternalMedicine,pfe:BiopharmaSegment█▅▄▅▄▃▂▃▁13001099102510851011910870889765NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService,us-gaap:ReportingUnit,us-gaap:StatementBusinessSegments pfe:Ibrance,pfe:Oncology,pfe:BiopharmaSegment▇███▅▅▃▃▁12481284128312611133113310251027933NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService,us-gaap:ReportingUnit,us-gaap:StatementBusinessSegments pfe:PrevnarPrevenarFamily,pfe:Vaccines,pfe:BiopharmaSegment▅▇▇▁▅▆█▂▄145015791603117914861512166012501380NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService,us-gaap:StatementBusinessSegments pfe:TotalAllianceBiopharmaceuticals,pfe:BiopharmaUpjohnAndConsumerHealthcareSegments█▄▁138212301141NA10901018977NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ProductOrService,us-gaap:StatementBusinessSegments pfe:TotalSterileInjectablePharmaceuticals,pfe:BiopharmaUpjohnAndConsumerHealthcareSegments█▅▁140713321248NA123712861239NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ReportingUnit,us-gaap:StatementBusinessSegments pfe:Hospital,pfe:BiopharmaSegment▆▇▃▃▂▆▁█▆201220551917191318872011184120772026NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ReportingUnit,us-gaap:StatementBusinessSegments pfe:InternalMedicine,pfe:BiopharmaSegment▇█▄▇▄▇▄▆▁233223652207233022172340218222762071NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ReportingUnit,us-gaap:StatementBusinessSegments pfe:Oncology,pfe:BiopharmaSegment██▇▆▃▃▂▂▁243524672350223619611984184018881760NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ReportingUnit,us-gaap:StatementBusinessSegments pfe:UpjohnReportingUnit,pfe:UpjohnSegment▁▂▂▆▇█▇██202221562195280730753182303631473120NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:ReportingUnit,us-gaap:StatementBusinessSegments pfe:Vaccines,pfe:BiopharmaSegment▅▆▇▁▅▅█▁▂161117091808137516121624184514001463NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments pfe:BiopharmaSegment▆█▆▄▂▅▃▃▁100071053210108959591859821942294348881NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementBusinessSegments pfe:BiopharmaUpjohnAndConsumerHealthcareSegments12028NA126801326413118NA132981346612906NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical country:US▅▄▅▇▆▇▇▆▇▇▇▇██▇▇▇█▅▃▁▃▃▃▁▃▄▃▄▅▅▆56515492585063356175646863616225627565106534634566376808653063356625671155654994443350504842490642755084518650905368562757225954NA6879670067007024NANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical pfe:DevelopedEurope▁▂▂▂▂▃▂▃▂▂▂▂▁▃▂▃▃▄▃▃▃▆▅▆▅▇▅▅▆▅██19212251213522282086245922312334209221992163212420212324221824402370270823152380231230782837300827953237278529133029297634973592NA4027421142113884NANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical pfe:DevelopedRestOfWorld▁▂▂▂▁▃▂▂▁▃▂▂▂▃▂▂▁▃▁▂▁▄▃▃▃▅▄▅▅▇██14561707158516391535175616401694146118151632161115541789171117181520173615131558149319101816186117282207199221082172252926932635NA2807264426442546NANANA
 us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:StatementGeographical pfe:EmergingMarkets▅▇▆▆██▆▇▆▇▄▄▂▃▂▂▁▄▃▅▂▆▄▅▂▆▃▄▅▄▇▇30013240311030623322329330663214307831772839281525672706258626552489289326942921262630802866299825553030268028622931284431453224NA2896293029303048NANANA
us-gaap:CostOfGoodsAndServicesSold ▁▃▃▃▁▇▄▅▂█▅▃237826082602257624333075269429162563325628442660NANANANANANANANANANANANA2045NA22872242265226652752297439083679380538053693379036844202
us-gaap:SellingGeneralAndAdministrativeExpense ▁▅▂▃▂▅▃▃▃▆▃▃▂▆▃▃▃█▂▃▂▅▃▃▂2873424032603511333940073494354234124551350034253308442335593471338550483270338631043981355635203040NA33953591358538473977413353714621497349734503459947744403
us-gaap:InterestExpense ▇██▇▅▆▃▃▃▄▃▃▃▂▂▂▂▄▁▁▃▅▄▄▃390416409389361370310326310330320312309297291292306335278278309353343343321NA340356391382379390396423404404458427389522
us-gaap:OtherNonoperatingIncomeExpense ▇▁▆▇▇▁██▇▅▇▇▇▅▄▅▆▃▆▇▇▆▇▇▆-221-3041-319-126-92-3259414551178-1331-51661-840-1417-1068-330-2190-661-5546-344-9453-623NA120-29-128-3239-206-98-10525251-3-18-52
us-gaap:IncomeLossFromContinuingOperations ▃▁▅▄▃▁▃▃▃█▃▃▃▂▂▂▃▁▂▃▃▂▃▃▂3401-337767650463884-39441033872356212274284030713121843132020193016-1692122262623711249266929122256NA2582356527383104318717941482242325802580221285124442005
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest ▄▁█▄▄▁▄▄▄▂▄▄▄▂▃▃▄▂▃▄▄▃▄▄▃3885-15081072741414323-946417745274127954358538153951776160424103561-3542697353930821803358740032847NA3573535739212991448425532293366936823682311814143926NA
 us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest us-gaap:ConsolidationItems us-gaap:OperatingSegments▇▅▇██▅▇▇▆▃▆▅▆▁▅▅▆▃▅▄▁792072397856804481627418791579187719687776407453765562987315737776846778719969086190NANANANANANANANANANANANANANANANANANANA
 us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,pfe:BiopharmaSegment█▃▆▃▂▁▄▂▂672960336503609358885751620659585823NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,pfe:UpjohnSegment▁▁▂▆█▇▇█▇119112081353195122742194205122222168NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest ▃▁▅▄▃▁▃▃▃█▃▃▃▂▂▂▃▁▂▃▃▂▃▃▂3410-327768050563889-38341113879357112289285830773130849132020353026-1662130263523761257267629212265NA2588357527613110319418031493243425882588222485624542014
us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity ▄▅▃▅▃▅▄▄▄▇█▃▄▃▁▇▄▂▄▄▃▄▃▄▄9104106118791518596016939967699NA610NA67NANANANANANANANANA
us-gaap:IncomeTaxExpenseBenefit ▇▆█▆▇▆▇▇▇▁▇▇▇▆▇▇▇▆▇▇▇▇▇▇▇475-11823047-915433-56466648556-11336727739821-71284375535-1885679057065459111082582NA98517821160-119129075080012351094109489455814721135
us-gaap:IncomeTaxesPaidNet ▁▄▂█▁█▂239102850019012351989469NA2571065NANA1951091NANA518969290752372616416532536NANANA554NANA451NANANANA-134NANA10547
us-gaap:ProfitLoss ▃▁▅▄▃▁▃▃▃█▃▃▃▂▂▂▃▁▂▃▃▂▃▃▃3410-326768450563889-38341223879357012289285830783130866131920353026-1692139263523811236267229212338NA25991413427653214326018031450374926182618223487124852035
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:Parent▄▁█▆▅▁▅▅▄3401-336768050463884-393411438723561NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▄▁█▆▅▁▅▅▄3401-336768050463884-393411438723561NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:ComprehensiveIncomeNetOfTax ▃▂▆▄▄▂▄▄▄█▄▄▄▁▃▄▄▂▃▄▃▁▃▄▃1911-176741544344236-125237003270348012117385734863563-1963199726473019-523148126631134-2621235131502210NA267213785254835638672301NA3480371237123602157410-468
us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest ▅▅▂▆▃▅▃▂▅▆▇▆▆▄▃▇▄▃▃▅▁▄▃█▄910-6121110-4101419131540214028-1041247NA-3218125-108NA7121216528-10
us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest ▃▂▆▄▄▂▄▄▄█▄▄▄▁▃▄▄▂▃▄▃▁▃▄▃1920-166740944464237-124137003266349012132387634993579-1959199726683022-523148326701124-2617235231742217NA264013803256035688572309-15123487372437243618157938-478
us-gaap:NetIncomeLoss ▃▁▅▄▃▁▃▃▃█▃▃▃▂▂▂▃▁▂▃▃▂▃▃▃3401-336768050463884-39341143872356112274284030733121860132020193016-1722130262623761228266629122329NA25901409527503208325317941439373826102610222286624752026
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic ▃▁▅▄▃▁▃▃▃█▃▃▃▂▂▂▃▁▂▃▃▂▃▃▃3401-337768050453883-39441143871356012274283930733121859131920193016-1722130262623751228266629112329NA25931409927423207325317941438373826102610222286524742025
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted ▃▁▅▄▃▁▃▃▃█▃▃▃▂▂▂▃▁▂▃▃▂▃▃▃3401-336768050463884-39341143872356112274284030733121859132020193016-1712130262623761227266629122329NA25931409927423208325317941439373826102610222286624752026
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest ▄▅▃▅▃▅▄▄▄▇█▃▄▃▁▇▄▂▄▄▃▄▃▄▄9104106118791518596016939967699NA93915679111188125109
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:Assets ▃▃▄▁▁▂▃▃▃▄▄▃▃▄▅▄▂▃▄▂▂▃▄▄▄▄▄▅▆▆▆▆▇████166336167489170446156199155421159000167838165000164612172000172151168558168784171615178430170658162929167460170867160878160640169274171362172612171808172101175521179335187398182603182842185683188002196132195899195899194956NANANA
us-gaap:Liabilities ▄▅▅▂▂▂▂▂▁▃▇▆▆▇█▆▃▄▄▁▁▂▁▂▁▂▂▃▅▃▄▄▅▅▅▅▅100998104042105051962749626395664961749485694071100141111041109863110038111776114829107592995821024631037439369893053976529305795656937409548197167100358104571100488102881102006105381105602106936106936104423NANANA
us-gaap:LiabilitiesAndStockholdersEquity ▃▃▄▁▁▂▃▃▃▄▄▃▃▄▅▄▂▃▄▂▂▃▄▄▄▄▄▅▆▆▆▆▇████166336167489170446156199155421159422167838164980164612171797172151168558168784171615178430170658162929167460170867160878160640169274171362172612171808172101175521179335187398182603182842185683188002196132195899195899194956NANANA
us-gaap:StockholdersEquity ▂▂▂▁▁▂▄▄▄▄▂▁▁▁▂▂▂▂▃▃▃▄▅▅▅▅▅▅▆▆▆▆▆████65026631436510359568588066340771319697787018471308607705836858435595446330662769630686472066838668946730471301779887663377769763077796978547822508170379547832568219090047884818848190067NANANA
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:AssetsCurrent ▁▁▁▄▄▅▃▂▁▃▃▂▂▂▂▃▃▃▄▅▅▆▆▇▆▆▇▇█▆▇▆▆█▇▇▇34738328033345947073452904992641583373033483541141402913638535878389493850143845412984380445001517154944357702569875828757793562445950061435647635712758765548635772862732604846048458244NANANA
us-gaap:CashAndCashEquivalentsAtCarryingValue ▄▂▅▃▃▂▆▅▄▂▅▄▇▄▄▆▄▆▅▆▆▆▄▆▅▄▃▄▄█▅▅▆▇▅▅▁▄▃▃215113052785178419371139355927042302134227792585405725952094341125613641309936703563334324373406286221832052243621344506303129343539370630963096730217618771759
us-gaap:ShortTermInvestments ▁▂▁▂▂▄▃▂▂▄▃▂▂▃▃▄▄▄▄▆▆█▇▇▇▇█▇█▄▅▅▅▆▅▅▅819985256302111289682176941368010727911918650141461174810503152551227717531168821964917559265862414532779310093064831019302253162731275332121846221275210382321925257223882238823279NANANA
us-gaap:AccountsReceivableNetCurrent ▃▂▂▃▂▁▃▃▂▁▃▂▂▁▃▂▂▁▂▂▂▂▃▃▂▂▄▄▅▅▅▇▆█▇▇▇988187249439979395998025100249873945282211000294768892822598369138903381769535895189208669995510388939993571137111523127351252312882141821360815749151921519215182NANANA
us-gaap:InventoryNet █▇▇▇▇▅▇▇▇▆▆▆▅▄▅▆▆▅▆▁▁▁▃▂▂▂▃▂▄▅▄▅▆████8423828382228233802975088184807481487578792575847415678375077614757875137678579657865663635562496066616664826282703575167001718977698426859785978467NANANA
us-gaap:OtherAssetsCurrent ▄▄▅▄▄▃▃▃▂▃▂▁▂▂▅▆▃▂▂▃▅▅▄▄▇█27372600295425352567246124502343212622892158187722182249284330232355216322482449281527502545272734733613NANANANANANANANANANANANANANA
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment █▇▇▇▆▇██▇▆▆▅▄▄▄▃▂▁169291678916728163891615816591170781684416665161721590615506150501480714838146371400213502NANANA13226NANANA13281NANANANANANA13584NANANANANANANA
us-gaap:PropertyPlantAndEquipmentNet ▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▃▁▁▁▂▂▂▂▂▂▃▄▄▆▆▇▇▇█14040139671370113521134671338514036139191397113865135051338613238133181328413609135841376613695114321152711762120321217912347123971235912443139501460614756161921693817721182811828118833NANANA
us-gaap:LongTermInvestments █▁▁▁▁▁▃▃▃▃▃▃▃▃▄▆▆▇▇████▇▇▇▇▇▇▆▄▅▄182203014272329052859276764446595694570157311700873467116950713124141461599916233176501828917518184511716815822164061573116107153921342910548106329814NANANANANANANA
us-gaap:Goodwill ███▆▆▆▇▇▇▇▇▇▆▆▇▅▄▄▃▁▁▁▁▁▁▁▁▁▂▂▂▃▂▃▂▂▂58502586535866553352534875341155614558365639355952560785501454656544495628150600485584824247217415714185442069427244266142467425194240042431437524437044568452524506745409451074510744853NANANA
 us-gaap:Goodwill us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,pfe:BiopharmaSegment███▇▁▁4808148202482064288000NANANA43359NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:Goodwill us-gaap:ConsolidationItems,us-gaap:StatementBusinessSegments us-gaap:OperatingSegments,pfe:UpjohnSegment████▁▁1042110451104601047200NANANA10600NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:IntangibleAssetsNetExcludingGoodwill ▁▂▃▁▁▂▄▅▅▅▆▆▆▆▇▄▃▃▄▁▁▂▂▂▂▃▃▃▄▅▅▆▇▇███34464353703899533024340393521145306465844769048741497215134852427526485423843056396024035643297334243433435166363743736038122393854054941776441094720948399528015383355597570595705958497NANANA
us-gaap:FiniteLivedIntangibleAssetsNet ▁▁▃▂▃▃▅▄▅▅▅▆▆▅▅▃▃▃▄▁▁▂▂▃▃▃▄▄▅▆▆▇▇▇███25482263872997229070299633104536012344943553736562374923903340009356643675030425315303216534775257822669427506285702965730430315583267333711357853823739373413564253741902433354333544545NANANA
 us-gaap:FiniteLivedIntangibleAssetsNet us-gaap:FiniteLivedIntangibleAssetsByMajorClass us-gaap:DevelopedTechnologyRights▁▁▃▃▃▃▅▄▄▅▅▆▆▄▅▃▃▃▄▁▁▂▂▂▃▃▄▄▅▆▆▇▇▇███24736256252918028590294653053534337327533372634765356253719138133337403483028569295433041933041246152549326252272602843129388304973159332586344533674437811396804107540356417464174642974NANANA
us-gaap:OtherAssetsNoncurrent ▆▆█▆▆▁▂▁▁▂▃▃▃▃▇▇▅▃▅▄▄▃▃▄▄▄41664450492043884333279929802896289632273388346633293323475946184003349939113635371635133421357437593596NANANANANANANANANANANANANANA
 us-gaap:OtherAssetsNoncurrent us-gaap:BalanceSheetLocation,us-gaap:FairValueByFairValueHierarchyLevel,us-gaap:FairValueByMeasurementFrequency us-gaap:OtherNoncurrentAssets,us-gaap:FairValueInputsLevel2,us-gaap:FairValueMeasurementsRecurring▁█10201102NANANA1082NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:OtherAssetsNoncurrent us-gaap:BalanceSheetLocation,us-gaap:FairValueByMeasurementFrequency us-gaap:OtherNoncurrentAssets,us-gaap:FairValueMeasurementsRecurring▁█10201102NANANA1082NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:LiabilitiesCurrent ▇██▆▅▆▅▆▄▅▄▄▃▆▇▆▅▅▄▃▁▂▁▂▃▂▁▂▄▅▅▄▄▄▅▅▅33890373043697432030294233185829013321562736530427282172718224864311153475932099287352939927845241432022221631199202193824790233662037323450275432913130798270942806927856304713047129171NANANA
us-gaap:DebtCurrent ███▅▄▄▃▅▄▄▄▄▃▅▆▆▅▄▄▃▂▂▂▂▄▂▁▂▄▃▃▂▁▂▂▂▂16007161951661710507941088317385115839010995394489514768010688136331372411546101609818839465555141538955619319602747385214889677747703552640185637598859886093NANANA
us-gaap:LongTermDebtCurrent ▁▃▄▄██▇▇█▆▅▅▆▇3371462243121394471477642554262476335463072307232924225NANANA3720NANANA3011NANANA2060NANANANANANA6NANANANANANANA
 us-gaap:LongTermDebtCurrent us-gaap:LongtermDebtType us-gaap:UnsecuredDebt▁▃▄▄██▇▇█▆337146224312139447147764255426247633546NANANA4225NANANA3720NANANA3011NANANA2060NANANANANANANANANANANANANANA
us-gaap:AccountsPayableCurrent ▆▇▆▆▇█▇▇▆█▅▅▅█▅▄▄▅▄▃▃▅▄▄▂▄▂▁▄▄▄▄▆▆▅▅▆3972422039424002415646744297419638794656348034393393453634763261312536203294293027243440297329902546323422871978327929673165309138363765369836983750NANANA
us-gaap:TaxesPayableCurrent ▃▃▅▄▅▄█▇▅▁▃▁▂▁▃▂▂▁▃▃▃▁▂▂▂▂▂▂▃▅▆▅▃▆▅▅▆115098018921536184912652781248116144771003552790437115864792041811781057944531892760851678802904115817882098193010132215184918491958NANANA
us-gaap:OtherLiabilitiesCurrent ▅▅▄▄▄▅▅▄▅▆▄▄▆▅█▅▆▅▃▁▁▂▂▃▄▄105151108310160101101027610753104901012510950111151044610148111431102312623110531141910990967283908320902488249346103159951NANANANANANANANANANANANANANA
us-gaap:DividendsPayableCurrent ▁███▁███▁█▇▇▁▇▇▇▁▇▇▇▁▇▁▆▁▇▁▇▁▁▇▁▇021041992199102047196319800202919091904019441821182001852172817260171101650116631168551182611796NANANANANANANA
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
 us-gaap:LongTermDebt us-gaap:DebtInstrument,us-gaap:LongtermDebtType pfe:SeniorUnsecuredDebtTwoPointSixTwoFivePercentDue2030,us-gaap:SeniorNotes1250NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:DerivativeInstrumentRisk pfe:ForeignCurrencyLongTermDebt▁▁▁▁▁▄▄▄▄█1900200019002000200032003200320033004800NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:LongtermDebtType us-gaap:SeniorNotes▁██████1250500050005000500050005000NANANA57975631NANA50005000NANANANANANANANANANANA2400NANANANANANANANANANANANA
 us-gaap:LongTermDebt us-gaap:LongtermDebtType us-gaap:UnsecuredDebt▁▁▁▁▁▁▁▁▄▄█▄▄▄18001800180018001800180018001800190019002000190019001900NANANA28818NANANA3154145004500NA30462NANANANANANANANANANANANANANA
us-gaap:LongTermDebtNoncurrent █████▆▆▃▅▆▇▆█▄▄▄▂▃▃▁▃▅▅▅▂▄▅▅▄▄▄▆▇▇██▇36281359553604436168357333290933652289353183133538345033419136330313983043730457278242881829079267292937031541316663226727649304623181231532314813108330868335433493135399357233572335308NANANA
 us-gaap:LongTermDebtNoncurrent us-gaap:LongtermDebtType us-gaap:UnsecuredDebt████▇▅▅▁▄▅36281359553604436168357333290933652289353183133538NANANA31398190020002100NANANANANANANANANANANANANANANANANANANANANANANA
us-gaap:MinorityInterest ▂▂▁▃▃▃▃▃▃▃▂▂▂▁▁▁▁▁▁▁▁▂▂▂▁▂▄▅█▄▄▄▅▆▆▆▅312303293357352351346346358348340326311296294297279278286286283321317323299313385430577412414421431483482482466NANANA
us-gaap:OtherLiabilitiesNoncurrent █▆▇▆▇▅▇▅▅▆▇▇█▆▆▄▃▄▃▄▅▃▁▁▁▂▂▄▃▄▅▃▆▆▃▃▃6812631763816183634658506367594756446149638864406918633760595518518052574987531056444883426642384416476745155231513852615836511961996239493249324970NANANA
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:StockholdersEquity ▂▂▂▁▁▂▄▄▄▄▂▁▁▁▂▂▂▂▃▃▃▄▅▅▅▅▅▅▆▆▆▆▆████65026631436510359568588066340771319697787018471308607705836858435595446330662769630686472066838668946730471301779887663377769763077796978547822508170379547832568219090047884818848190067NANANA
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest ▂▂▂▁▁▂▄▄▄▄▂▁▁▁▂▂▂▂▃▃▃▄▅▅▅▅▅▅▆▆▆▆▆████65338634476539659924591586375871664701247054171656611105869458746598406360163066633476499867124671806758771622783057695678068766207835478977828278211579961836778262190530889638896390533NANANA
 us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents us-gaap:AdditionalPaidInCapital█▇▇▇▆▅▄▂▂▁87680874288709986963866358625385828848988459984278NANANA82685NANANA81016NANANA78977NANANA77283NANANANANANA71423NANANANANANANA
 us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents us-gaap:Parent▄▃▅▁▁▄█▇▇█65026631436510359568588066340771319697787018471308NANANA59544NANANA64720NANANA71301NANANA76307NANANANANANA82190NANANANANANANA
 us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest us-gaap:StatementEquityComponents us-gaap:RetainedEarnings█▇█▅▅▃▄▃▃▁1010009767010011394440933888955491995898608996185291NANANA71774NANANA71993NANANA72176NANANA69732NANANANANANA46210NANANANANANANA
us-gaap:CommonStockValue █▇▇▇▇▇▇▇▇▆▆▆▆▆▆▆▅▅▅▅▅▄▄▄▄▃▃▃▃▂▂▂▁▁▁▁▁470468468468468467466465465464463463463461461461460459459458458455455454454453452451450447447446445445445445444NANANA
us-gaap:AdditionalPaidInCapital █████▇▇▇▇▇▆▆▆▆▆▆▅▅▅▅▅▄▄▄▄▄▃▃▃▂▁▁▁▁▁▁▁87680874288709986963866358625385828848988459984278838278337383111826858253482138814438101680763804078000478977784987820877849772837675676412757787231772027717867142371235710957109570925NANANA
us-gaap:RetainedEarningsAccumulatedDeficit ███▇▇▇▇▇▇▆▅▅▅▄▅▅▅▄▅▅▅▄▅▄▄▄▄▄▃▂▁▁▁▁▁▁▁1010009767010011394440933888955491995898608996185291750437410774847717747284673350749717199374019736207447172176742927162772028697327038167628569725125647904481244621048121443204432044926NANANA
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax ▁▂▂▂▂▂▃▃▃▃▃▃▂▂▄▃▃▃▃▄▄▄▇▇▇▇▅▅▅▅▅▆▆███▇-13131-11640-11801-11535-10923-11275-10417-10003-9402-9321-9164-10181-10594-11036-8214-8891-9520-9522-9170-8521-8557-7316-3467-3152-3390-3271-6383-6465-6155-5653-6008-3622-4129-1211-952-952-2056NANANA
us-gaap:TreasuryStockValue █████▇▇▇▇▆▆▆▆▆▆▆▆▅▅▅▅▅▅▅▅▅▄▄▃▂▂▂▂▁▁▁▁11101011080111079511078611078110161096574954639546089425894218941689414843648434684313843137925279259790987910073021718207053569204679236327259515448323670334863335193180128586264712647124215NANANA
us-gaap:MinorityInterest ▂▂▁▃▃▃▃▃▃▃▂▂▂▁▁▁▁▁▁▁▁▂▂▂▁▂▄▅█▄▄▄▅▆▆▆▅312303293357352351346346358348340326311296294297279278286286283321317323299313385430577412414421431483482482466NANANA
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:NetCashProvidedByUsedInOperatingActivities ▄▅▇▃▁▇█3133376945102611169847385259NA19836742NANA15895972NANA16514713502440906855398446340872935NANANA2241NANA27745261NANANA4642NANA-6360
us-gaap:NetCashProvidedByUsedInInvestingActivities ▄▃▁▃█▄▃-71-2833-6760-19027550-764-2904NA9667-4779NANA4772-3107NANA4355-2224-5243-21056592-1514-2535-1507-98NANANA-10930NANA451899NANANA725NANA9394
us-gaap:NetCashProvidedByUsedInFinancingActivities ▅▅█▆▁▂▅-2200-24403273-851-8467-6407-1406NA-10720-3385NANA-4921-2228NANA-7014-1109-267-1875-6982-2926-2887-2040-2133NANANA434NANA-3507-6250NANANA-6404NANA-3211
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:NetCashProvidedByUsedInOperatingActivities ▄▅▇▃▁▇█3133376945102611169847385259NA19836742NANA15895972NANA16514713502440906855398446340872935NANANA2241NANA27745261NANANA4642NANA-6360
us-gaap:NetIncomeLoss ▃▁▅▄▃▁▃▃▃█▃▃▃▂▂▂▃▁▂▃▃▂▃▃▃3401-336768050463884-39341143872356112274284030733121860132020193016-1722130262623761228266629122329NA25901409527503208325317941439373826102610222286624752026
us-gaap:ProfitLoss ▃▁▅▄▃▁▃▃▃█▃▃▃▂▂▂▃▁▂▃▃▂▃▃▃3410-326768450563889-38341223879357012289285830783130866131920353026-1692139263523811236267229212338NA25991413427653214326018031450374926182618223487124852035
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:Parent▄▁█▆▅▁▅▅▄3401-336768050463884-393411438723561NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
 us-gaap:ProfitLoss us-gaap:StatementEquityComponents us-gaap:RetainedEarnings▄▁█▆▅▁▅▅▄3401-336768050463884-393411438723561NANANANANANANANANANANANANANANANANANANANANANANANANANANANANANANA
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:NetCashProvidedByUsedInInvestingActivities ▄▃▁▃█▄▃-71-2833-6760-19027550-764-2904NA9667-4779NANA4772-3107NANA4355-2224-5243-21056592-1514-2535-1507-98NANANA-10930NANA451899NANANA725NANA9394
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment ▁█▄▂▁█▄463672565479460685547NA386700NANA358689NANA301611289258239354275278292NANANA202NANA254598NANANA250NANA305
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:NetCashProvidedByUsedInFinancingActivities ▅▅█▆▁▂▅-2200-24403273-851-8467-6407-1406NA-10720-3385NANA-4921-2228NANA-7014-1109-267-1875-6982-2926-2887-2040-2133NANANA434NANA-3507-6250NANANA-6404NANA-3211
us-gaap:ProceedsFromIssuanceOfLongTermDebt ▃▁▁▁█▁█1241000494204974NA01NANA52735945NANA000NANA0044910NANANA2624NANA0NANANANANANANANA
us-gaap:RepaymentsOfLongTermDebt ▆▃▂▆█▂▁21811000451235130044620NA3551680NANA12533372NANA153601030021318340752NANANA2NANA33500NANANA3878NANA9
us-gaap:PaymentsForRepurchaseOfCommonStock ▁▁▁▁█▅▂0000886550301105NA60630NANA50000NANA50000160060001199128113231197NANANA4626NANA16593211NANANA1430NANANA
  2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
us-gaap:RepaymentsOfLongTermDebt ▆▃▂▆█▂▁21811000451235130044620NA3551680NANA12533372NANA153601030021318340752NANANA2NANA33500NANANA3878NANA9

Common Stock Value

us-gaap:CommonStockValue



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value470468468468468467466465465464463463463461461461460459459458458455455454454453452451450448447447446445445445444444443
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.20.20.20.20.20.20.20.20.20.20.2

Common Stock Par Or Stated Value Per Share

Shares Issued

us-gaap:StatementEquityComponents

us-gaap:SharesIssued

us-gaap:CommonStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value93939369936693639358933293269303929992759230917891109051895689028876886988638850
Percentage of SharesIssued100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PreferredStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value0000000000007170000000
Percentage of SharesIssued0.00.00.00.00.00.00.00.00.00.00.00.07.90.00.00.00.00.00.00.0

us-gaap:TreasuryStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value38413835-3835-380138013615-3484-34383437329631603003-28192652-1680-1327-864-799-2117-2089
Percentage of SharesIssued40.940.9-40.9-40.640.638.7-37.4-37.037.035.534.232.7-30.929.3-18.8-14.9-9.7-9.0-23.9-23.6

Common Stock Shares Issued

Common Stock Shares Authorized

Weighted Average Number Of Diluted Shares Outstanding

us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-022017-04-022016-10-022016-07-032016-04-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value56135649567257505986595260576041603760926138613762146243624362926403644464766656711772697508753775987810793579358035805780728101
Percentage of WeightedAverageNumberOfDilutedSharesOutstanding100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Weighted Average Number Of Shares Outstanding Basic

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-022017-04-022016-10-022016-07-032016-04-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value55455545556256355875586659575951595860066066606861506168615962036330636863896581704271877436747675377770787578757982802780468061
Percentage of WeightedAverageNumberOfSharesOutstandingBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Basic

us-gaap:EarningsPerShareBasic



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value0.61-0.060000000000000051.380.910.69-0.060000000000000050.70.660.62.05999999999999960.480.520.520.13999999999999990.220.330.49-0.0200000000000000180.350.430.380.199999999999999960.420.460.360.392.00.380.430.440.240.189999999999999950.480.330.330.280.110.310.25
Percentage of EarningsPerShareBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Earnings Per Share Diluted

us-gaap:EarningsPerShareDiluted



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value0.61-0.049999999999999821.360.890.68-0.049999999999999820.690.650.592.03000000000000020.470.510.510.13999999999999990.210.330.49-0.0299999999999998050.340.420.380.189999999999999950.420.450.360.391.980.380.430.430.240.189999999999999950.480.330.330.280.110.310.25
Percentage of EarningsPerShareDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Income Loss From Continuing Operations Per Basic Share

us-gaap:IncomeLossFromContinuingOperationsPerBasicShare



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value0.61-0.060000000000000051.380.910.69-0.060000000000000050.70.660.62.05999999999999960.480.520.520.13999999999999990.220.330.49-0.0200000000000000180.340.430.380.199999999999999960.420.460.350.390.510.380.420.430.240.190000000000000060.310.330.320.280.110.30.25
Percentage of IncomeLossFromContinuingOperationsPerBasicShare100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Income Loss From Continuing Operations Per Diluted Share

us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value0.61-0.049999999999999821.360.890.68-0.059999999999999830.690.650.592.03000000000000020.470.510.510.13999999999999990.220.330.49-0.0299999999999998050.340.420.380.189999999999999950.420.450.350.390.50.380.410.420.240.200000000000000070.310.330.320.280.110.30.25
Percentage of IncomeLossFromContinuingOperationsPerDilutedShare100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Revenue From Contract With Customer Excluding Assessed Tax

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value12028126881268013264131181397713298134661290613703131681289612779136281304513147130051404712087118531086413118123611277311353135581264312973135001397615057154051674617193169841648516502159951713216576
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems

us-gaap:CorporateNonSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value0-2098377862858-263183988690500000000000
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0-16.53.06.56.5-18.86.36.67.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.0-16.53.06.56.5-18.86.36.67.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:CorporateNonSegment0.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:MaterialReconcilingItems



Period End2020-03-292019-03-31
Value0858
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.06.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.06.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:MaterialReconcilingItems0.0100.0

us-gaap:OperatingSegments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-02
Value120281268912303124021225913977132981346612001137031316812896
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.097.093.593.5100.0100.0100.093.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.097.093.593.5100.0100.0100.093.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value100071053210108959591859821942294348881
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax83.283.079.772.370.070.370.970.168.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax83.283.079.772.370.070.370.970.168.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OperatingSegments, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value202221562195280730753182303631473120
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.817.017.321.223.422.822.823.424.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.817.017.321.223.422.822.823.424.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:Currency, us-gaap:StatementGeographical

currency:EUR, pfe:DevelopedEurope



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value15001800170018001700200018001900170018001700170016001900170019001800200018001800180024002200230022002500210022002100
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.514.213.413.613.014.313.514.113.213.112.913.212.513.913.014.513.814.214.915.216.618.317.818.019.418.416.617.015.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.514.213.413.613.014.313.514.113.213.112.913.212.513.913.014.513.814.214.915.216.618.317.818.019.418.416.617.015.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax currency:EUR pfe:DevelopedEurope100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProductOrService, us-gaap:ReportingUnit, us-gaap:StatementBusinessSegments

pfe:AllOtherInflammationandImmunologyProducts, pfe:InflammationandImmunology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value22515639141111
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.00.10.00.00.10.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.20.00.10.00.00.10.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:AllOtherInflammationandImmunologyProducts pfe:InflammationandImmunology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:AllOtherInternalMedicine, pfe:InternalMedicine, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value480654597631639761727750730
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.05.24.74.84.95.45.55.65.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.05.24.74.84.95.45.55.65.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:AllOtherInternalMedicine pfe:InternalMedicine pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:AllOtherRareDiseaseProducts, pfe:RareDisease, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value313528357247384376
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.30.20.30.50.30.30.30.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.30.20.30.50.30.30.30.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:AllOtherRareDiseaseProducts pfe:RareDisease pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:AllOtherUpjohnProducts, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value492405379523400411
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.13.23.04.02.93.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax4.13.23.04.02.93.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:AllOtherUpjohnProducts pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0

pfe:BMP2, pfe:InternalMedicine, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value697566796773548073
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.50.60.50.50.40.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.50.60.50.50.40.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:BMP2 pfe:InternalMedicine pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:BeneFIX, pfe:RareDisease, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value121116125121125134132141147
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.91.00.91.01.01.01.01.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.00.91.00.91.01.01.01.01.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:BeneFIX pfe:RareDisease pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Bosulif, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value1009890978090697760
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.80.70.70.60.60.50.60.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.80.80.70.70.60.60.50.60.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Bosulif pfe:Oncology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Braftovi, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-03-31
Value370
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Braftovi pfe:Oncology pfe:BiopharmaSegment100.00.0

pfe:Celebrex, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value156193179174174192188161145
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.51.41.31.31.41.41.21.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.51.41.31.31.41.41.21.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Celebrex pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:ChantixChampix, pfe:InternalMedicine, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value270282276276273296261277251
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.22.22.22.12.12.12.02.11.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.22.22.22.12.12.12.02.11.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:ChantixChampix pfe:InternalMedicine pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Effexor, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value779480867783787971
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.70.60.60.60.60.60.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.70.60.60.60.60.60.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Effexor pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Eliquis, pfe:InternalMedicine, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value13001099102510851011910870889765
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.88.78.18.27.76.56.56.65.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.88.78.18.27.76.56.56.65.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Eliquis pfe:InternalMedicine pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Enbrel, pfe:InflammationandImmunology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value347414415420451523531551506
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.93.33.33.23.43.74.04.13.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.93.33.33.23.43.74.04.13.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Enbrel pfe:InflammationandImmunology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:EpiPen, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-03-31
Value7256
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:EpiPen pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0

pfe:Fragmin, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value596862636072767470
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.50.50.50.50.60.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.50.50.50.50.60.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Fragmin pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Genotropin, pfe:RareDisease, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value103141124125107142143140132
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.91.11.00.90.81.01.11.01.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.91.11.00.90.81.01.11.01.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Genotropin pfe:RareDisease pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Ibrance, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value12481284128312611133113310251027933
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.410.110.19.58.68.17.77.67.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax10.410.110.19.58.68.17.77.67.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Ibrance pfe:Oncology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:InflectraRemsima, pfe:InflammationandImmunology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value158179155153138173166158145
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.41.21.21.11.21.21.21.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.41.21.21.11.21.21.21.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:InflectraRemsima pfe:InflammationandImmunology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Inlyta, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value1691611391047372718174
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.31.10.80.60.50.50.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.41.31.10.80.60.50.50.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Inlyta pfe:Oncology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Lipitor, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value405467476407622523507521511
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.43.73.83.14.73.73.83.94.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.43.73.83.14.73.73.83.94.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Lipitor pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Lyrica, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value357433527117511861321121312231213
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.03.44.28.99.09.59.19.19.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.03.44.28.99.09.59.19.19.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Lyrica pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Medrol, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value129121109120120124110123136
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.00.90.90.90.90.80.91.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.11.00.90.90.90.90.80.91.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Medrol pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Mektovi, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-03-31
Value370
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.30.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Mektovi pfe:Oncology pfe:BiopharmaSegment100.00.0

pfe:Nimenrix, pfe:Vaccines, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value7571525850454630
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.40.40.40.30.30.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.40.40.40.30.30.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Nimenrix pfe:Vaccines pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Norvasc, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value197215219216300252248273256
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.71.71.62.31.81.92.02.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.71.71.62.31.81.92.02.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Norvasc pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:OtherAntiinfectives, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value444153335367354112300362392
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.71.22.62.82.70.82.32.73.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.71.22.62.82.70.82.32.73.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:OtherAntiinfectives pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:OtherHospitalProducts, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value684526656623631673669748708
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.74.15.24.74.84.85.05.65.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.74.15.24.74.84.85.05.65.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:OtherHospitalProducts pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:OtherOncologyProducts, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value192129194140153104101100119
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.01.51.11.20.70.80.70.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.01.51.11.20.70.80.70.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:OtherOncologyProducts pfe:Oncology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:OtherVaccinesProducts, pfe:Vaccines, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value8619164312625214783
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.10.10.31.00.20.20.30.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.10.10.31.00.20.20.30.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:OtherVaccinesProducts pfe:Vaccines pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Panzyga, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-03-31
Value7417
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Panzyga pfe:Hospital pfe:BiopharmaSegment100.0100.0

pfe:PfizerCentreOne, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value152254176176216159
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.32.01.41.31.51.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.32.01.41.31.51.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:PfizerCentreOne pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0

pfe:PremarinFamily, pfe:InternalMedicine, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value152192182193168227204210191
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.51.41.51.31.61.51.61.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.31.51.41.51.31.61.51.61.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:PremarinFamily pfe:InternalMedicine pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:PrevnarPrevenarFamily, pfe:Vaccines, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value145015791603117914861512166012501380
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.112.412.68.911.310.812.59.310.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.112.412.68.911.310.812.59.310.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:PrevnarPrevenarFamily pfe:Vaccines pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:ReFactoAfXyntha, pfe:RareDisease, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value89107104108106126117141130
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.80.80.80.80.90.91.01.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.80.80.80.80.90.91.01.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:ReFactoAfXyntha pfe:RareDisease pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Retacrit, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value8978645131271918
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.60.50.40.20.20.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.70.60.50.40.20.20.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Retacrit pfe:Oncology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Somavert, pfe:RareDisease, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value647264685972646863
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.60.50.50.40.50.50.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.60.50.50.40.50.50.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Somavert pfe:RareDisease pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Sulperazon, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value187179163165177149145150168
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.41.31.21.31.11.11.11.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.61.41.31.21.31.11.11.11.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Sulperazon pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Sutent, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value205232224248232264248275262
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.81.81.91.81.91.92.02.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.81.81.91.81.91.92.02.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Sutent pfe:Oncology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Toviaz, pfe:InternalMedicine, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value606461656074677060
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.50.50.50.50.50.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.50.50.50.50.50.50.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Toviaz pfe:InternalMedicine pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Vfend, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value7481879485988711098
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.70.70.60.70.70.80.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.70.70.60.70.70.80.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Vfend pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Viagra, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value127118120114145127137185187
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.10.90.90.91.10.91.01.41.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.10.90.90.91.10.91.01.41.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Viagra pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Vyndaqel, pfe:RareDisease, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value2312141566341403738
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.91.71.20.50.30.30.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.91.71.20.50.30.30.30.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Vyndaqel pfe:RareDisease pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0

pfe:XalatanXalacom, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value618068726285768572
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.60.50.50.50.60.60.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.50.60.50.50.50.60.60.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:XalatanXalacom pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Xalkori, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value149145130133123107127137153
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.21.11.01.00.90.81.01.01.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.21.11.01.00.90.81.01.01.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Xalkori pfe:Oncology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Xeljanz, pfe:InflammationandImmunology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value451608599613423553432463326
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.74.84.74.63.24.03.23.42.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.74.84.74.63.24.03.23.42.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Xeljanz pfe:InflammationandImmunology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:XtandiAllianceRevenues, pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value209244225168189180
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.91.81.31.41.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.71.91.81.31.41.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:XtandiAllianceRevenues pfe:Oncology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0

pfe:ZithromaxZmax, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value138827773104836181101
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.10.60.60.60.80.60.50.60.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax1.10.60.60.60.80.60.50.60.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:ZithromaxZmax pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Zoloft, pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value787774736975727774
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.60.60.50.50.50.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.60.60.60.50.50.50.60.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Zoloft pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Zyvox, pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value705661716452506668
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.40.50.50.50.40.40.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.60.40.50.50.50.40.40.50.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Zyvox pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProductOrService, us-gaap:StatementBusinessSegments

pfe:TotalAllianceBiopharmaceuticals, pfe:BiopharmaUpjohnAndConsumerHealthcareSegments



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value13821230114110901018977
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.59.79.08.37.37.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.59.79.08.37.37.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:TotalAllianceBiopharmaceuticals pfe:BiopharmaUpjohnAndConsumerHealthcareSegments100.0100.0100.0100.0100.0100.0

pfe:TotalBiosimilars, pfe:BiopharmaUpjohnAndConsumerHealthcareSegments



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value288279236179211197
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.42.21.91.41.51.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.42.21.91.41.51.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:TotalBiosimilars pfe:BiopharmaUpjohnAndConsumerHealthcareSegments100.0100.0100.0100.0100.0100.0

pfe:TotalSterileInjectablePharmaceuticals, pfe:BiopharmaUpjohnAndConsumerHealthcareSegments



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value140713321248123712861239
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.710.59.89.49.29.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax11.710.59.89.49.29.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:TotalSterileInjectablePharmaceuticals pfe:BiopharmaUpjohnAndConsumerHealthcareSegments100.0100.0100.0100.0100.0100.0

us-gaap:ReportingUnit, us-gaap:StatementBusinessSegments

pfe:ConsumerHealthcareReportingUnit, pfe:ConsumerHealthcare



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value00377862858974839886905
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.03.06.56.57.06.36.67.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.00.03.06.56.57.06.36.67.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:ConsumerHealthcareReportingUnit pfe:ConsumerHealthcare0.00.0100.0100.0100.0100.0100.0100.0100.0

pfe:Hospital, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value201220551917191318872011184120772026
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.716.215.114.414.414.413.815.415.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.716.215.114.414.414.413.815.415.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Hospital pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:InflammationandImmunology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value97812511226121910371301118412221013
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.19.99.79.27.99.38.99.17.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax8.19.99.79.27.99.38.99.17.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:InflammationandImmunology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:InternalMedicine, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value233223652207233022172340218222762071
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax19.418.617.417.616.916.716.416.916.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax19.418.617.417.616.916.716.416.916.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:InternalMedicine pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Oncology, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value243524672350223619611984184018881760
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax20.219.418.516.914.914.213.814.013.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax20.219.418.516.914.914.213.814.013.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Oncology pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:RareDisease, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value639686601521470560531571549
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.35.44.73.93.64.04.04.24.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax5.35.44.73.93.64.04.04.24.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:RareDisease pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:UpjohnReportingUnit, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value202221562195280730753182303631473120
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.817.017.321.223.422.822.823.424.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.817.017.321.223.422.822.823.424.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:UpjohnReportingUnit pfe:UpjohnSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:Vaccines, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value161117091808137516121624184514001463
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.413.514.310.412.311.613.910.411.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax13.413.514.310.412.311.613.910.411.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:Vaccines pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementBusinessSegments

pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value100071053210108959591859821942294348881
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax83.283.079.772.370.070.370.970.168.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax83.283.079.772.370.070.370.970.168.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:BiopharmaSegment100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:BiopharmaUpjohnAndConsumerHealthcareSegments



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-01
Value12028126801326413118132981346612906
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:BiopharmaUpjohnAndConsumerHealthcareSegments100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementGeographical

country:US



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value56515492585063356175646863616225627565106534634566376808653063356625671155654994443350504842490642755084518650905368562757225954687967007024
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax47.043.346.147.847.146.347.846.248.647.549.649.251.950.050.148.250.947.846.042.140.838.539.238.437.737.541.039.239.840.338.038.640.039.442.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax47.043.346.147.847.146.347.846.248.647.549.649.251.950.050.148.250.947.846.042.140.838.539.238.437.737.541.039.239.840.338.038.640.040.642.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax country:US100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:DevelopedEurope



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value19212251213522282086245922312334209221992163212420212324221824402370270823152380231230782837300827953237278529133029297634973592402742113884
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.017.716.816.815.917.616.817.316.216.016.416.515.817.117.018.618.219.319.220.121.323.523.023.524.623.922.022.522.421.323.223.323.424.823.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.017.716.816.815.917.616.817.316.216.016.416.515.817.117.018.618.219.319.220.121.323.523.023.524.623.922.022.522.421.323.223.323.425.523.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:DevelopedEurope100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:DevelopedRestOfWorld



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value14561707158516391535175616401694146118151632161115541789171117181520173615131558149319101816186117282207199221082172252926932635280726442546
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.113.512.512.411.712.612.312.611.313.212.412.512.213.113.113.111.712.412.513.113.714.614.714.615.216.315.816.216.118.117.917.116.315.615.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax12.113.512.512.411.712.612.312.611.313.212.412.512.213.113.113.111.712.412.513.113.714.614.714.615.216.315.816.216.118.117.917.116.316.015.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:DevelopedRestOfWorld100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:EmergingMarkets



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value30013240311030623322329330663214307831772839281525672706258626552489289326942921262630802866299825553030268028622931284431453224289629303048
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax25.025.524.523.125.323.623.123.923.823.221.621.820.119.919.820.219.120.622.324.624.223.523.223.522.522.321.222.121.720.320.920.916.817.318.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax25.025.524.523.125.323.623.123.923.823.221.621.820.119.919.820.219.120.622.324.624.223.523.223.522.522.321.222.121.720.320.920.916.817.818.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:EmergingMarkets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Sales Revenue Net

Sales Revenue Goods Net

Cost Of Goods And Services Sold

us-gaap:CostOfGoodsAndServicesSold



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value237826082602257624333075269429162563325628442660204522872242265226652752297439083679380535713693379036844202
Percentage of CostOfGoodsAndServicesSold100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax19.820.620.519.418.522.020.321.719.923.821.620.618.018.117.319.619.118.319.323.321.422.421.722.423.721.525.3

Cost Of Goods Sold

Costs And Expenses

Selling General And Administrative Expense

us-gaap:SellingGeneralAndAdministrativeExpense



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value287342403260351133394007349435423412455135003425330844233559347133855048327033863104398135563520304033953591358538473977413353714621497348004503459947744403
Percentage of SellingGeneralAndAdministrativeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax23.933.425.726.525.528.726.326.326.433.226.626.625.932.527.326.426.035.927.128.628.630.328.827.626.826.927.726.627.526.426.832.126.929.329.127.328.827.926.6

Interest Expense

us-gaap:InterestExpense



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value390416409389361370310326310330320312309297291292306335278278309353343343321340356391382379390396423404404458427389522
Percentage of InterestExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.23.33.22.92.82.62.32.42.42.42.42.42.42.22.22.22.42.42.32.32.82.72.82.72.82.72.72.92.72.52.52.42.52.42.52.82.72.33.1

Other Nonoperating Income Expense

us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value-221-3041-319-126-92-3259414551178-1331-51661-840-1417-1068-330-2190-661-5546-344-9453-623120-29-128-3239-206-98-10525161-3-18-52
Percentage of OtherNonoperatingIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-1.8-24.0-2.5-0.9-0.7-23.33.14.11.4-9.7-0.40.50.0-6.2-10.9-8.1-2.5-15.6-5.5-0.50.4-2.6-0.80.4-5.50.9-0.2-0.9-0.20.3-1.3-0.6-0.60.10.10.0-0.0-0.1-0.3

Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax

us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax

pfe:GSKConsumerHealthcare



Period End2020-03-29
Value-1200
Percentage of OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-10.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax pfe:GSKConsumerHealthcare0.0

Income Loss From Continuing Operations

us-gaap:IncomeLossFromContinuingOperations



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value3401-337767650463884-39441033872356212274284030713121843132020193016-16921222626237112492669291222562582356527383104318717941482242325802513221285124442005
Percentage of IncomeLossFromContinuingOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.3-2.760.538.029.6-2.830.928.827.689.621.623.824.46.210.115.423.2-1.217.622.221.89.521.622.819.920.427.520.322.221.211.68.814.115.215.213.45.314.312.1

Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest

us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-04
Value3885-15081072741414323-946417745274127954358538153951776160424103561-35426973539308218033587400328473573535739212991448425532293366936823598311814143926
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax32.3-11.984.631.233.0-6.831.433.632.07.027.229.630.95.712.318.327.4-2.522.329.928.413.729.031.325.128.341.329.021.429.816.613.721.321.721.818.98.822.9

us-gaap:ConsolidationItems

us-gaap:CorporateNonSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value-1110-1751-1431-1399-1278-1463-1337-1144-1153-1574-1382-1222-1344-1203-1504-1256-1363-1481-1376-1286-1287-1406-1308-1287-1200-1580-1340
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-28.6116.1-13.3-33.8-29.6154.7-32.0-25.3-27.9-165.0-38.5-32.0-34.0-155.0-93.8-52.1-38.3418.4-51.0-36.3-41.8-78.0-36.5-32.2-42.10.0-37.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-9.2-13.8-11.3-10.5-9.7-10.5-10.1-8.5-8.9-11.5-10.5-9.5-10.5-8.8-11.5-9.6-10.5-10.5-11.4-10.8-11.8-10.7-10.6-10.1-10.6-11.7-10.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:CorporateNonSegment0.083.5-379.6-162.3-149.055.6-159.4-129.1-127.40.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:MaterialReconcilingItems



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-28
Value-1489-1973-1443-1193-1113-847-736-669-725-932-759-758-688-994-786-708-668-964-715-715
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-38.3130.8-13.5-28.8-25.789.5-17.6-14.8-17.6-97.7-21.2-19.9-17.4-128.1-49.0-29.4-18.8272.3-26.5-20.2
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-12.4-15.6-11.4-9.0-8.5-6.1-5.5-5.0-5.6-6.8-5.8-5.9-5.4-7.3-6.0-5.4-5.1-6.9-5.9-6.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:MaterialReconcilingItems0.00.00.00.0-129.70.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:OperatingSegments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-29
Value792072397856804481627418791579187719687776407453765562987315737776846778719969086190
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest203.9-480.073.2194.3188.8-784.1189.5174.9187.0720.9213.1195.4193.7811.6456.0306.1215.8-1914.7266.9195.2200.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax65.857.162.060.662.253.159.558.859.850.258.057.859.946.256.156.159.148.359.658.357.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments65.857.063.964.966.653.159.558.864.350.258.057.80.00.00.00.00.00.00.00.00.0

us-gaap:ConsolidationItems, pfe:OtherSegmentReconcilingItems

us-gaap:MaterialReconcilingItems, pfe:BusinessCombinationsAcquisitionRelatedCosts



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-312017-10-012017-07-022017-04-022016-10-022016-07-032016-04-03
Value-13-33-300176-28-97-112-62-109-155-68-124-280-202-116
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-0.32.2-2.84.3-0.610.3-2.7-1.4-11.4-4.3-1.8-3.1-17.5-8.4-3.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.1-0.3-2.41.3-0.2-0.7-0.8-0.5-0.8-1.2-0.5-1.0-2.1-1.5-0.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:MaterialReconcilingItems pfe:BusinessCombinationsAcquisitionRelatedCosts0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:MaterialReconcilingItems, pfe:CertainSignificantItems



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-312017-10-012017-07-022017-04-022016-10-022016-07-032016-04-03
Value-612-40147187-309-382-4171298237-1626-449-191-157-1969-1506-638
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-15.8266.267.0-7.5-8.8440.97.15.2-170.4-12.5-5.0-4.0-122.8-62.5-17.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-5.1-31.656.7-2.3-2.9-29.82.21.8-11.9-3.4-1.5-1.2-15.1-11.5-4.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:MaterialReconcilingItems pfe:CertainSignificantItems0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:MaterialReconcilingItems, pfe:PurchaseAccountingAdjustments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-312017-10-012017-07-022017-04-022016-10-022016-07-032016-04-03
Value-812-976-1141-1178-1038-1121-1309-1134-1231-1154-1201-1172-966-984-1153
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest-20.964.7-10.6-28.4-24.0118.5-31.3-25.0-129.0-32.2-31.5-29.7-60.2-40.8-32.4
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-6.8-7.7-9.0-8.9-7.9-8.0-9.8-8.4-9.0-8.8-9.3-9.2-7.4-7.5-8.9
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:MaterialReconcilingItems pfe:PurchaseAccountingAdjustments0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value672960336503609358885751620659585823
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest173.2-400.160.6147.1136.2-607.9148.6131.6141.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax55.947.551.345.944.941.146.744.245.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments pfe:BiopharmaSegment67.257.364.363.564.158.665.963.265.6

us-gaap:OperatingSegments, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value119112081353195122742194205122222168
Percentage of IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest30.7-80.112.647.152.6-231.949.149.152.5
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax9.99.510.714.717.315.715.416.516.8
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:OperatingSegments pfe:UpjohnSegment58.956.061.669.574.069.067.670.669.5

Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest

us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value3410-327768050563889-38341113879357112289285830773130849132020353026-16621302635237612572676292122652588357527613110319418031493243425882521222485624542014
Percentage of IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.4-2.660.638.129.6-2.730.928.827.789.721.723.924.56.210.115.523.3-1.217.622.221.99.621.622.920.020.527.620.522.321.211.78.914.215.215.313.55.414.312.2

Income Loss From Continuing Operations Before Income Taxes Domestic

Income Loss From Continuing Operations Before Income Taxes Foreign

Income Loss From Continuing Operations Attributable To Noncontrolling Entity

us-gaap:IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302012-09-302012-07-01
Value910410611879151859601693996769961067
Percentage of IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.10.00.10.10.10.10.10.10.00.10.00.00.10.10.00.10.10.10.10.00.10.10.00.10.00.0

Income Tax Expense Benefit

us-gaap:IncomeTaxExpenseBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value475-11823047-915433-56466648556-11336727739821-71284375535-188567905706545911108258298517821160-119129075080012351094107789455814721135
Percentage of IncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax3.9-9.324.0-6.93.3-4.00.54.84.3-82.75.55.76.4-0.52.22.94.1-1.34.77.66.54.27.48.55.17.813.78.6-0.98.64.94.87.26.46.55.43.58.66.8

Income Taxes Paid Net

us-gaap:IncomeTaxesPaidNet



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-04-032010-04-04
Value23910285001901235198946925710651951091518969290752372616416532536554451-13410547
Percentage of IncomeTaxesPaidNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax2.08.13.914.31.814.23.52.07.81.58.04.06.92.46.33.44.73.44.24.74.12.9-0.863.6

Profit Loss

us-gaap:ProfitLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value3410-326768450563889-38341223879357012289285830783130866131920353026-169213926352381123626722921233825991413427653214326018031450374926182618223487124852035
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.4-2.660.638.129.6-2.731.028.827.789.721.723.924.56.410.115.523.3-1.217.722.221.99.421.622.920.620.6108.920.523.021.711.78.721.815.415.913.55.414.512.3

us-gaap:StatementEquityComponents

us-gaap:NoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value910410611879
Percentage of ProfitLoss0.3-3.10.10.20.2-2.90.20.20.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.10.00.10.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.0

us-gaap:Parent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value3401-336768050463884-393411438723561
Percentage of ProfitLoss99.7103.199.999.899.9102.699.899.899.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.3-2.660.638.029.6-2.830.928.827.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Parent0.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value3401-336768050463884-393411438723561
Percentage of ProfitLoss99.7103.199.999.899.9102.699.899.899.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.3-2.660.638.029.6-2.830.928.827.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.0

Comprehensive Income Net Of Tax

us-gaap:ComprehensiveIncomeNetOfTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value1911-176741544344236-125237003270348012117385734863563-1963199726473019-523148126631134-26212351315022102672137852548356386723013480371237123602157410-468
Percentage of ComprehensiveIncomeNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax15.9-1.458.533.432.3-9.027.824.327.088.429.327.027.9-14.415.320.123.2-3.712.322.510.4-20.019.024.719.521.1106.318.925.55.814.920.221.922.521.89.80.1-2.8

Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest

us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value910-6121110-4101419131540214028-1041247-3218125-1087121216528-10
Percentage of ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.1-0.00.10.00.10.0-0.00.10.10.10.10.10.00.00.20.00.00.00.1-0.10.00.00.20.1-0.30.10.10.0-0.10.10.00.10.10.10.00.2-0.1

Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest

us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value1920-166740944464237-124137003266349012132387634993579-1959199726683022-523148326701124-2617235231742217264013803256035688572309-15123487372437243618157938-478
Percentage of ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax16.0-1.358.433.532.3-8.927.824.327.088.529.427.128.0-14.415.320.323.2-3.712.322.510.3-19.919.024.819.520.9106.419.025.55.715.0-9.020.321.922.621.99.90.2-2.9

Net Income Loss

us-gaap:NetIncomeLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value3401-336768050463884-39341143872356112274284030733121860132020193016-172213026262376122826662912232925901409527503208325317941439373826102610222286624752026
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.3-2.660.638.029.6-2.830.928.827.689.621.623.824.46.310.115.423.2-1.217.622.221.99.421.622.820.520.5108.620.423.021.611.68.621.715.415.813.55.414.412.2

Net Income Loss Available To Common Stockholders Basic

us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value3401-337768050453883-39441143871356012274283930733121859131920193016-172213026262375122826662911232925931409927423207325317941438373826102610222286524742025
Percentage of NetIncomeLossAvailableToCommonStockholdersBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.3-2.760.638.029.6-2.830.928.727.689.621.623.824.46.310.115.423.2-1.217.622.221.99.421.622.820.520.5108.720.322.921.611.68.621.715.415.813.55.414.412.2

Net Income Loss Available To Common Stockholders Diluted

us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value3401-336768050463884-39341143872356112274284030733121859132020193016-171213026262376122726662912232925931409927423208325317941439373826102610222286624752026
Percentage of NetIncomeLossAvailableToCommonStockholdersDiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.3-2.660.638.029.6-2.830.928.827.689.621.623.824.46.310.115.423.2-1.217.622.221.99.421.622.820.520.5108.720.323.021.611.68.621.715.415.813.55.414.412.2

Net Income Loss Attributable To Noncontrolling Interest

us-gaap:NetIncomeLossAttributableToNoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value910410611879151859601693996769993915679111188125109
Percentage of NetIncomeLossAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.10.00.10.10.10.10.10.10.00.10.00.00.10.10.00.10.10.10.10.00.10.10.10.30.10.00.00.10.10.10.00.00.10.00.10.1

Assets

us-gaap:Assets



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value166336167489170446156199155421159000167838165000164612172000172151168558168784171615178430170658162929167460170867160878160640169274171362172612171808172101175521179335187398185798182603182842185683188002196132195899194956195014212949
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value1581186315131467133312601594177315901523794
Percentage of Assets1.01.10.90.90.90.80.91.11.00.90.5
Percentage of Assets1.01.10.90.90.90.80.91.11.00.90.5
Percentage of Assets us-gaap:FairValueInputsLevel1 us-gaap:FairValueMeasurementsRecurring100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value9042931372901133410512183351727214668135972341421403
Percentage of Assets5.45.64.37.36.811.510.38.98.313.612.5
Percentage of Assets5.45.64.37.36.811.510.38.98.313.612.5
Percentage of Assets us-gaap:FairValueInputsLevel2 us-gaap:FairValueMeasurementsRecurring100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementFrequency

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value106231117688031280111845195951886616440151882493722197
Percentage of Assets6.46.75.28.27.612.311.210.09.214.512.9
Percentage of Assets6.46.75.28.27.612.311.210.09.214.512.9
Percentage of Assets us-gaap:FairValueMeasurementsRecurring100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Liabilities

us-gaap:Liabilities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value100998104042105051962749626395664961749485694071100141111041109863110038111776114829107592995821024631037439369893053976529305795656937409548197167100358104571104120100488102881102006105381105602106936104423106749122503
Percentage of Liabilities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets60.762.161.661.661.960.257.357.557.158.264.565.265.265.164.463.061.161.260.758.257.957.754.355.454.655.555.456.055.856.055.056.354.956.153.854.653.654.757.5

Liabilities And Stockholders Equity

us-gaap:LiabilitiesAndStockholdersEquity



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value166336167489170446156199155421159422167838164980164612171797172151168558168784171615178430170658162929167460170867160878160640169274171362172612171808172101175521179335187398185798182603182842185683188002196132195899194956195014212949
Percentage of LiabilitiesAndStockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets100.0100.0100.0100.0100.0100.3100.0100.0100.099.9100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Stockholders Equity

us-gaap:StockholdersEquity



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value650266314365103595685880663407713196977870184713086077058368584355954463306627696306864720668386689467304713017798876633777697630777969785478225081260817037954783256821909004788481900678781390014
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets39.137.738.238.137.839.942.542.342.641.535.334.634.634.735.536.838.738.639.141.641.942.145.544.445.344.344.443.843.943.744.743.544.843.745.945.246.245.042.3

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCredit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value549584591658693728776814855750783814847879919889855880960992703733313259
Percentage of StockholdersEquity0.80.90.91.11.21.11.11.21.21.11.31.41.41.51.51.41.41.41.41.51.01.00.40.3
Percentage of Assets0.30.30.30.40.40.50.50.50.50.40.50.50.50.50.50.50.50.50.60.60.40.40.20.1
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCredit0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value-6296-6257-5933-5911-5986-6027-5538-5657-5764-5262-5210-5198-5278-5473-4423-4538-4585-4733-5303-5330-5398-5654-3223-6110
Percentage of StockholdersEquity-9.7-9.9-9.1-9.9-10.2-9.5-7.8-8.1-8.2-7.4-8.6-8.9-9.0-9.2-7.0-7.2-7.3-7.3-7.9-8.0-8.0-7.9-4.2-7.5
Percentage of Assets-3.8-3.7-3.5-3.8-3.9-3.8-3.3-3.4-3.5-3.1-3.0-3.1-3.1-3.2-2.5-2.7-2.8-2.8-3.1-3.3-3.4-3.3-1.9-3.3
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLoss0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-312016-12-312015-12-31
Value-3442060-33167167248267-30348421
Percentage of StockholdersEquity-0.50.00.1-0.10.30.30.30.4-0.00.60.7
Percentage of Assets-0.20.00.0-0.00.10.10.10.2-0.00.20.3
Percentage of Assets us-gaap:AccumulatedGainLossNetCashFlowHedgeParent0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value-67-350-8-24-68-131-230-28401339221108-13129517269-227913-271-222150236
Percentage of StockholdersEquity-0.1-0.10.0-0.0-0.0-0.1-0.2-0.3-0.00.60.60.40.2-0.20.50.30.1-0.40.10.0-0.4-0.30.20.3
Percentage of Assets-0.0-0.00.0-0.0-0.0-0.0-0.1-0.1-0.00.20.20.10.1-0.10.20.10.0-0.10.10.0-0.2-0.10.10.1
Percentage of Assets us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value-13131-11640-11801-11535-10923-11275-10417-10003-9402-9321-9164-10181-10594-11036-8214-8891-9520-9522-9170-8521-8557-7316-3271-5953
Percentage of StockholdersEquity-20.2-18.4-18.1-19.4-18.6-17.8-14.6-14.3-13.4-13.1-15.1-17.4-18.1-18.5-13.0-14.2-15.1-14.7-13.7-12.7-12.7-10.3-4.3-7.3
Percentage of Assets-7.9-6.9-6.9-7.4-7.0-7.1-6.2-6.1-5.7-5.4-5.3-6.0-6.3-6.4-4.6-5.2-5.8-5.7-5.4-5.3-5.3-4.3-1.9-3.2
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value-6973-5952-6519-6242-5772-6075-5772-5198-4375-5180-5021-5957-6417-6659-4847-5265-5776-5863-4926-4404-4067-2689-590-177
Percentage of StockholdersEquity-10.7-9.4-10.0-10.5-9.8-9.6-8.1-7.4-6.2-7.3-8.3-10.2-11.0-11.2-7.7-8.4-9.2-9.1-7.4-6.6-6.0-3.8-0.8-0.2
Percentage of Assets-4.2-3.6-3.8-4.0-3.7-3.8-3.4-3.2-2.7-3.0-2.9-3.5-3.8-3.9-2.7-3.1-3.5-3.5-2.9-2.7-2.5-1.6-0.3-0.1
Percentage of Assets us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Assets Current

us-gaap:AssetsCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value347383280333459470734529049926415833730334835411414029136385358783894938501438454129843804450015171549443577025698758287577935624459500614356476361415571275876554863577286273260484582446046861670
Percentage of AssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets20.919.619.630.129.131.424.822.621.223.923.421.621.322.721.625.725.326.226.332.130.834.133.333.833.632.733.934.334.633.131.332.129.530.732.030.929.931.029.0

Cash And Cash Equivalents At Carrying Value

us-gaap:CashAndCashEquivalentsAtCarryingValue



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312010-10-032010-07-042010-04-042010-01-042009-12-312009-09-272008-12-312007-12-31
Value2151130527851784193711393559270423021342277925854057259520943411256136413099367035633343243734062862218320522436213410389450630312934353937063096730173521761877175919781978423421223406
Percentage of CashAndCashEquivalentsAtCarryingValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.30.81.61.11.20.72.11.61.40.81.61.52.41.51.22.01.62.21.82.32.22.01.42.01.71.31.21.41.15.62.51.71.61.91.91.60.40.90.00.00.00.00.90.00.00.0

Short Term Investments

us-gaap:ShortTermInvestments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value8199852563021112896821769413680107279119186501414611748105031525512277175311688219649175592658624145327793100930648310193022531627312753321222319184622127521038232192525722388232792627723991
Percentage of ShortTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.95.13.77.16.211.18.26.55.510.88.27.06.28.96.910.310.411.710.316.515.019.418.117.818.117.618.017.417.712.010.111.611.312.412.911.411.913.511.3

Accounts Receivable Net Current

us-gaap:AccountsReceivableNetCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value98818724943997939599802510024987394528234822110002947688928225983691389033817695358951892086699955103889399935711371115231273512378125231288214182136081574915192151821461214645
Percentage of AccountsReceivableNetCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.95.25.56.36.25.06.06.05.70.04.85.85.65.34.85.55.45.54.95.65.65.65.15.86.05.55.46.56.46.86.76.97.07.67.28.07.87.87.56.9

Inventory Net

us-gaap:InventoryNet



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value84238283822282338029750881848074814875677578792575847415678375077614757875137678579657865663635562496066616664826282703570637516700171897769842685978467840512403
Percentage of InventoryNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets5.14.94.85.35.24.74.94.94.90.04.44.64.54.44.04.24.54.74.54.53.63.63.33.73.63.53.63.73.53.83.84.13.83.94.14.34.44.34.35.8

Other Assets Current

us-gaap:OtherAssetsCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312019-01-012018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312012-12-31
Value2737260029542535256724602461245023432126228921581877221822492843302323552163224824492815275025452727347336133567
Percentage of OtherAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets1.61.61.71.61.70.01.51.51.41.31.31.31.11.31.31.61.81.41.31.31.51.81.61.51.62.02.11.9

Land

Machinery And Equipment Gross

Noncurrent Assets

Property Plant And Equipment Gross

Accumulated Depreciation Depletion And Amortization Property Plant And Equipment

us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Value169291678916728163891615816591170781684416665161721590615506150501480714838146371400213502132261328113421135841317511144
Percentage of AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets10.210.09.810.510.410.410.210.210.19.49.29.28.98.68.38.68.68.17.87.77.27.26.85.2

Property Plant And Equipment Net

us-gaap:PropertyPlantAndEquipmentNet



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value140401396713701135211346713385140361391913971138651350513386132381331813284136091358413766136951143211527117621203212179123471239712359124431395014461146061475616192169381772118281188331912322780
Percentage of PropertyPlantAndEquipmentNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets8.48.38.08.78.78.48.48.48.58.17.87.97.87.87.48.08.38.28.07.17.26.97.07.17.27.27.06.97.47.88.08.18.79.09.09.39.79.810.7

Long Term Investments

us-gaap:LongTermInvestments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-31
Value18220301427232905285927676444659569457015731170087346711695071312414146159991623317650182891751818451171681582216406157311610715392141491342910548106329814
Percentage of LongTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets11.01.81.61.91.81.73.84.04.24.14.24.24.44.15.37.78.79.69.511.011.410.310.89.99.29.59.09.08.27.67.45.85.75.2

Investments In Affiliates Subsidiaries Associates And Joint Ventures

Goodwill

us-gaap:Goodwill



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-312008-12-31
Value58502586535866553352534875341155614558365639355952560785501454656544495628150600485584824247217415714185442069427244266142467425194240042431437524467244370445684525245067454094510744853439474237621464
Percentage of Goodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets35.235.034.434.234.433.633.133.834.332.532.632.632.431.731.529.629.828.827.625.826.124.924.924.724.724.724.223.723.324.024.324.424.424.023.223.023.022.519.90.0

us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312017-12-31
Value480814820248206428800043359
Percentage of Goodwill82.282.282.280.40.00.077.5
Percentage of Assets28.928.828.327.50.00.025.2
Percentage of Assets us-gaap:OperatingSegments pfe:BiopharmaSegment0.00.00.00.00.00.00.0

us-gaap:OperatingSegments, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312017-12-31
Value104211045110460104720010600
Percentage of Goodwill17.817.817.819.60.00.018.9
Percentage of Assets6.36.26.16.70.00.06.2
Percentage of Assets us-gaap:OperatingSegments pfe:UpjohnSegment0.00.00.00.00.00.00.0

Intangible Assets Net Excluding Goodwill

us-gaap:IntangibleAssetsNetExcludingGoodwill



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value344643537038995330243403935211453064658447690487414972151348524275264854238430563960240356432973342434334351663637437360381223938540549417764410946013472094839952801538335559757059584975755868015
Percentage of IntangibleAssetsNetExcludingGoodwill100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets20.721.122.921.121.922.127.028.229.028.328.930.531.130.730.425.224.324.125.320.821.420.821.221.622.222.923.123.323.524.825.926.528.428.628.329.130.029.531.9

Finite Lived Intangible Assets Net

us-gaap:FiniteLivedIntangibleAssetsNet



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value254822638729972290702996331045360123449435537365623749239033400093566436750304253153032165347752578226694275062857029657304303155832673337113578537427382373937341356425374190243335445454382949549
Percentage of FiniteLivedIntangibleAssetsNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets15.315.817.618.619.319.521.520.921.621.321.823.223.720.820.617.819.419.220.416.016.616.216.717.217.718.318.618.819.120.120.921.522.322.621.422.122.822.523.3

us-gaap:FiniteLivedIntangibleAssetsByMajorClass

pfe:LicensingAgreementsAndOther



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282013-12-31
Value57458260328129229677781884781585981884086481683984170174215216015916491
Percentage of FiniteLivedIntangibleAssetsNet2.32.22.01.01.01.02.22.42.42.22.32.12.12.42.22.82.72.22.10.60.60.60.60.3
Percentage of Assets0.30.30.40.20.20.20.50.50.50.50.50.50.50.50.50.50.50.40.40.10.10.10.10.1
Percentage of Assets pfe:LicensingAgreementsAndOther0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:DevelopedTechnologyRights



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value247362562529180285902946530535343373275333726347653562537191381333374034830285692954330419330412461525493262522726028431293883049731593325863445336043367443781139680410754035641746429744220947647
Percentage of FiniteLivedIntangibleAssetsNet97.197.197.498.398.398.495.395.094.995.195.095.395.394.694.893.993.794.695.095.595.595.495.495.996.696.696.796.796.396.396.196.095.996.696.396.396.596.396.2
Percentage of Assets14.915.317.118.319.019.220.519.920.520.220.722.122.619.719.516.718.118.219.315.315.915.515.916.517.117.718.018.218.419.420.120.721.421.820.621.322.021.622.4
Percentage of Assets us-gaap:DevelopedTechnologyRights0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:TradeNames



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312012-12-31
Value1731811901982062158989239649821008102510371060110410161147104499210151041109611461129949970964
Percentage of FiniteLivedIntangibleAssetsNet0.70.70.60.70.70.72.52.72.72.72.72.62.63.03.03.33.63.22.93.93.94.04.03.83.13.12.6
Percentage of Assets0.10.10.10.10.10.10.50.60.60.60.60.60.60.60.60.60.70.60.60.60.60.60.70.70.60.60.5
Percentage of Assets us-gaap:TradeNames0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Deferred Tax Assets Liabilities Net

Other Assets Noncurrent

us-gaap:OtherAssetsNoncurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312019-01-012018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312012-12-31
Value41664450492043884333414927992980289628963023322733883466332933234759461840033499391136353716351334213574375935963233
Percentage of OtherAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.52.72.92.82.80.01.81.81.81.80.01.92.02.12.01.92.72.72.52.12.32.32.32.12.02.12.22.11.7

us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:OtherNoncurrentAssets, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312018-12-31
Value102011021082
Percentage of OtherAssetsNoncurrent24.524.838.7
Percentage of Assets0.60.70.7
Percentage of Assets us-gaap:OtherNoncurrentAssets us-gaap:FairValueInputsLevel2 us-gaap:FairValueMeasurementsRecurring0.00.00.0

us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency

us-gaap:OtherNoncurrentAssets, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312018-12-31
Value102011021082
Percentage of OtherAssetsNoncurrent24.524.838.7
Percentage of Assets0.60.70.7
Percentage of Assets us-gaap:OtherNoncurrentAssets us-gaap:FairValueMeasurementsRecurring0.00.00.0

Liabilities Current

us-gaap:LiabilitiesCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value338903730436974320302942331858290133215627365304272821727182248643111534759320992873529399278452414320222216311992021938247902336620373234502754328619291313079827094280692785630471291712860937225
Percentage of LiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets20.422.321.720.518.920.017.319.516.617.716.416.114.718.119.518.817.617.616.315.012.612.811.612.714.413.611.613.114.715.416.016.814.614.914.215.615.014.717.5

Debt Current

us-gaap:DebtCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value1600716195166171050794108831738511583901099539448951476801068813633137241154610160981883946555514153895561931960274738521488966424777477035526401856375988609356235469
Percentage of DebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets9.69.79.76.76.15.64.47.05.55.85.55.64.66.27.68.07.16.15.75.24.13.03.13.25.43.52.72.94.73.54.34.23.02.12.93.13.12.92.6

Long Term Debt Current

us-gaap:LongTermDebtCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-31
Value337146224312139447147764255426247633546307230723292422537203011206024496350227
Percentage of LongTermDebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.91.41.42.93.02.52.62.92.11.81.82.02.52.21.81.21.30.01.80.0

us-gaap:LongtermDebtType

us-gaap:UnsecuredDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-31
Value3371462243121394471477642554262476335464225372030112060
Percentage of LongTermDebtCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.91.41.42.93.02.52.62.92.12.52.21.81.2
Percentage of Assets us-gaap:UnsecuredDebt0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Accounts Payable Current

us-gaap:AccountsPayableCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value397242203942400241564674429741963879465634803439339345363476326131253620329429302724344029732990254632342287197832794264296731653091383637653698375040264370
Percentage of AccountsPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets2.42.52.32.62.72.92.62.52.42.72.02.02.02.61.91.91.92.21.91.81.72.01.71.71.51.91.31.11.72.31.61.71.72.01.91.91.92.12.1

Taxes Payable Current

us-gaap:TaxesPayableCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value11509801892153618491265278124811614477100355279043711586479204181178105794453189276085167880290411581010178820981930101322151849195894610107
Percentage of TaxesPayableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.70.61.11.01.20.81.71.51.00.30.60.30.50.30.60.40.60.20.70.70.60.30.50.40.50.40.50.50.60.51.01.11.00.51.10.91.00.54.7

Other Liabilities Current

us-gaap:OtherLiabilitiesCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312019-01-012018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312012-12-31
Value105151108310160101101027611011107531049010125109501099211115104461014811143110231262311053114191099096728390832090248824934610315995113812
Percentage of OtherLiabilitiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets6.36.66.06.56.60.06.86.36.16.70.06.56.16.06.66.47.16.57.06.65.75.25.25.35.15.46.05.87.4

Dividends Payable Current

us-gaap:DividendsPayableCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312010-12-31
Value02104199219910204719631980020291909190401944182118200185217281726017110165011663116855173411826117961601
Percentage of DividendsPayableCurrent0.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.00.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.01.31.21.30.01.31.21.20.01.21.11.10.01.11.01.10.01.11.01.10.01.00.01.00.01.00.00.90.00.90.01.00.01.00.8

Long Term Debt

us-gaap:DebtInstrument, us-gaap:LongtermDebtType

us-gaap:LongTermDebt

pfe:SeniorUnsecuredDebtTwoPointSixTwoFivePercentDue2030, us-gaap:SeniorNotes



Period End2020-03-29
Value1250
Percentage of LongTermDebt100.0
Percentage of Assets0.8
Percentage of Assets pfe:SeniorUnsecuredDebtTwoPointSixTwoFivePercentDue2030 us-gaap:SeniorNotes0.0

us-gaap:DerivativeInstrumentRisk

pfe:ForeignCurrencyLongTermDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-31
Value1900200019002000200032003200320033004800
Percentage of LongTermDebt152.00.00.00.00.00.00.00.00.00.0
Percentage of Assets1.11.21.11.31.32.01.91.92.02.8
Percentage of Assets pfe:ForeignCurrencyLongTermDebt0.00.00.00.00.00.00.00.00.00.0

us-gaap:LongtermDebtType

us-gaap:SeniorNotes



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302017-10-012017-07-022016-10-022016-07-032013-06-302012-12-31
Value1250500050005000500050005000579756315000500024002400
Percentage of LongTermDebt100.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets0.83.02.93.23.23.13.03.43.32.82.91.31.3
Percentage of Assets us-gaap:SeniorNotes0.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:UnsecuredDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312015-12-312014-12-312014-09-282014-06-292013-12-31
Value1800180018001800180018001800180019001900200019001900190028818315414500450030462
Percentage of LongTermDebt144.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets1.11.11.11.21.21.11.11.11.21.11.21.11.11.117.218.62.62.617.7
Percentage of Assets us-gaap:UnsecuredDebt0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Long Term Debt Noncurrent

us-gaap:LongTermDebtNoncurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value362813595536044361683573332909336522893531831335383450334191363303139830437304572782428818290792672929370315413166632267276493046231812315323148131036310833086833543349313539935723353083841043193
Percentage of LongTermDebtNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets21.821.521.123.223.020.720.117.519.319.520.020.321.518.317.117.817.117.217.016.618.318.618.518.716.117.718.117.616.816.717.016.918.118.618.018.218.119.720.3

us-gaap:LongtermDebtType

us-gaap:UnsecuredDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312016-10-022016-07-032016-04-03
Value3628135955360443616835733329093365228935318313353831398190020002100
Percentage of LongTermDebtNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.06.26.67.5
Percentage of Assets21.821.521.123.223.020.720.117.519.319.518.31.11.21.3
Percentage of Assets us-gaap:UnsecuredDebt0.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Deferred Tax Liabilities Noncurrent

Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent

Minority Interest

us-gaap:MinorityInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value312303293357352351346346358348340326311296294297279278286286283321317323299313385430577418412414421431483482466452432
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.30.20.20.20.20.20.20.20.20.20.2

Other Liabilities Noncurrent

us-gaap:OtherLiabilitiesNoncurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312019-01-012018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value68126317638161836346691058506367594756445690614963886440691863376059551851805257498753105644488342664238441647674515523151384939526158365119619962394932497056015611
Percentage of OtherLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets4.13.83.74.04.10.03.73.83.63.40.03.63.73.84.13.73.43.23.23.12.93.33.52.92.52.52.62.82.62.92.72.72.93.22.83.33.22.52.52.92.6

Stockholders Equity

us-gaap:StockholdersEquity



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value650266314365103595685880663407713196977870184713086077058368584355954463306627696306864720668386689467304713017798876633777697630777969785478225081260817037954783256821909004788481900678781390014
Percentage of StockholdersEquity100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets39.137.738.238.137.839.942.542.342.641.535.334.634.634.735.536.838.738.639.141.641.942.145.544.445.344.344.443.843.943.744.743.544.843.745.945.246.245.042.3

us-gaap:StatementEquityComponents

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCredit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value549584591658693728776814855750783814847879919889855880960992703733313259
Percentage of StockholdersEquity0.80.90.91.11.21.11.11.21.21.11.31.41.41.51.51.41.41.41.41.51.01.00.40.3
Percentage of Assets0.30.30.30.40.40.50.50.50.50.40.50.50.50.50.50.50.50.50.60.60.40.40.20.1
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCredit0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value-6296-6257-5933-5911-5986-6027-5538-5657-5764-5262-5210-5198-5278-5473-4423-4538-4585-4733-5303-5330-5398-5654-3223-6110
Percentage of StockholdersEquity-9.7-9.9-9.1-9.9-10.2-9.5-7.8-8.1-8.2-7.4-8.6-8.9-9.0-9.2-7.0-7.2-7.3-7.3-7.9-8.0-8.0-7.9-4.2-7.5
Percentage of Assets-3.8-3.7-3.5-3.8-3.9-3.8-3.3-3.4-3.5-3.1-3.0-3.1-3.1-3.2-2.5-2.7-2.8-2.8-3.1-3.3-3.4-3.3-1.9-3.3
Percentage of Assets us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLoss0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-312016-12-312015-12-31
Value-3442060-33167167248267-30348421
Percentage of StockholdersEquity-0.50.00.1-0.10.30.30.30.4-0.00.60.7
Percentage of Assets-0.20.00.0-0.00.10.10.10.2-0.00.20.3
Percentage of Assets us-gaap:AccumulatedGainLossNetCashFlowHedgeParent0.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value-67-350-8-24-68-131-230-28401339221108-13129517269-227913-271-222150236
Percentage of StockholdersEquity-0.1-0.10.0-0.0-0.0-0.1-0.2-0.3-0.00.60.60.40.2-0.20.50.30.1-0.40.10.0-0.4-0.30.20.3
Percentage of Assets-0.0-0.00.0-0.0-0.0-0.0-0.1-0.1-0.00.20.20.10.1-0.10.20.10.0-0.10.10.0-0.2-0.10.10.1
Percentage of Assets us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value-13131-11640-11801-11535-10923-11275-10417-10003-9402-9321-9164-10181-10594-11036-8214-8891-9520-9522-9170-8521-8557-7316-3271-5953
Percentage of StockholdersEquity-20.2-18.4-18.1-19.4-18.6-17.8-14.6-14.3-13.4-13.1-15.1-17.4-18.1-18.5-13.0-14.2-15.1-14.7-13.7-12.7-12.7-10.3-4.3-7.3
Percentage of Assets-7.9-6.9-6.9-7.4-7.0-7.1-6.2-6.1-5.7-5.4-5.3-6.0-6.3-6.4-4.6-5.2-5.8-5.7-5.4-5.3-5.3-4.3-1.9-3.2
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312013-12-312012-12-31
Value-6973-5952-6519-6242-5772-6075-5772-5198-4375-5180-5021-5957-6417-6659-4847-5265-5776-5863-4926-4404-4067-2689-590-177
Percentage of StockholdersEquity-10.7-9.4-10.0-10.5-9.8-9.6-8.1-7.4-6.2-7.3-8.3-10.2-11.0-11.2-7.7-8.4-9.2-9.1-7.4-6.6-6.0-3.8-0.8-0.2
Percentage of Assets-4.2-3.6-3.8-4.0-3.7-3.8-3.4-3.2-2.7-3.0-2.9-3.5-3.8-3.9-2.7-3.1-3.5-3.5-2.9-2.7-2.5-1.6-0.3-0.1
Percentage of Assets us-gaap:AccumulatedTranslationAdjustment0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Stockholders Equity Including Portion Attributable To Noncontrolling Interest

us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-312008-12-312007-12-31
Value6533863447653965992459158637587166470124705417165661110586945874659840636016306663347649986712467180675877162278305769567806876620783547897782827816788211579961836778262190530889639053388265904465774065124
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets39.337.938.438.438.140.142.742.542.941.735.534.834.834.935.637.038.938.839.341.842.142.345.744.645.444.544.644.044.244.045.043.745.143.946.245.446.445.342.50.00.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value-13131-11640-11801-11535-10923-11275-10417-10003-9402-9321-11036-9522-7316-3271-5953-4129-3440552-45692299
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-20.1-18.3-18.0-19.2-18.5-17.7-14.5-14.3-13.3-13.0-18.4-14.6-10.2-4.3-7.3-5.0-3.90.6-7.93.5
Percentage of Assets-7.9-6.9-6.9-7.4-7.0-7.1-6.2-6.1-5.7-5.4-6.4-5.7-4.3-1.9-3.2-2.2-1.80.30.00.0
Percentage of Assets us-gaap:AccumulatedOtherComprehensiveIncome0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:AdditionalPaidInCapital



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value8768087428870998696386635862538582884898845998427882685810167897777283726087142370760704977028369913
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest134.2137.8133.2145.1146.4135.3119.8121.1119.9117.6138.2124.6110.3100.988.986.480.277.9121.7107.4
Percentage of Assets52.752.251.155.755.754.251.151.551.449.048.248.446.744.939.138.036.333.10.00.0
Percentage of Assets us-gaap:AdditionalPaidInCapital0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:CommonStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value470468468468468467466465465464461459455453448445444443443442
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.70.70.70.80.80.70.70.70.70.60.80.70.60.60.50.50.50.50.80.7
Percentage of Assets0.30.30.30.30.30.30.30.30.30.30.30.30.30.30.20.20.20.20.00.0
Percentage of Assets us-gaap:CommonStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:NoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value312303293357352351346346358348296278321313418431452432184114
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.50.50.40.60.60.60.50.50.50.50.50.40.40.40.50.50.50.50.30.2
Percentage of Assets0.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.00.0
Percentage of Assets us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:Parent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value6502663143651035956858806634077131969778701847130859544647207130176307812608219087813900145755665010
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest99.599.599.699.499.499.499.599.599.599.599.599.699.699.699.599.599.599.599.799.8
Percentage of Assets39.137.738.238.137.839.942.542.342.641.534.738.642.144.343.743.745.042.30.00.0
Percentage of Assets us-gaap:Parent0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:PreferredStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value1717181819192020212124262933394552617393
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.10.10.10.10.1
Percentage of Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Percentage of Assets us-gaap:PreferredStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value1010009767010011394440933888955491995898608996185291717747199372176697325424046210-42716404264914249660
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest154.6153.9153.1157.6157.9140.5128.4128.1127.5119.0119.9110.8100.891.066.455.9-48.444.785.176.3
Percentage of Assets60.758.358.760.560.156.354.854.554.749.641.843.042.640.529.224.6-21.919.00.00.0
Percentage of Assets us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

us-gaap:TreasuryStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
Value-111010-110801-110795-110786-110781-101610-96574-95463-95460-89425-84364-79252-73021-67923-40121-31801-22712-21632-57391-56847
Percentage of StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest-169.9-174.6-169.4-184.9-187.3-159.4-134.8-136.1-135.3-124.8-141.0-121.9-102.0-88.6-49.1-38.5-25.7-23.9-99.4-87.3
Percentage of Assets-66.7-66.2-65.0-70.9-71.3-63.9-57.5-57.9-58.0-52.0-49.2-47.3-43.1-39.5-21.6-16.9-11.6-10.20.00.0
Percentage of Assets us-gaap:TreasuryStock0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Common Stock Value

us-gaap:CommonStockValue



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value470468468468468467466465465464463463463461461461460459459458458455455454454453452451450448447447446445445445444444443
Percentage of CommonStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.30.20.20.20.20.20.20.20.20.20.20.2

Additional Paid In Capital

us-gaap:AdditionalPaidInCapital



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value876808742887099869638663586253858288489884599842788382783373831118268582534821388144381016807638040780004789777849878208778497728376756764127577872608723177202771786714237123571095709257076070497
Percentage of AdditionalPaidInCapital100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets52.752.251.155.755.754.251.151.551.449.048.749.549.248.246.348.150.048.447.350.049.846.745.845.345.344.943.742.640.439.139.639.438.738.036.336.336.436.333.1

Retained Earnings Accumulated Deficit

us-gaap:RetainedEarningsAccumulatedDeficit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312019-01-012018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value101000976701001139444093388895748955491995898608996186466852917504374107748477177472846733507497171993740197362074471721767429271627720286973270381676285697254240512564790448124462104812144320449264271640426
Percentage of RetainedEarningsAccumulatedDeficit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets60.758.358.760.560.10.056.354.854.554.70.049.643.644.044.341.840.843.046.043.043.345.846.442.643.441.541.940.540.137.730.429.228.126.225.924.624.522.623.021.919.0

Accumulated Other Comprehensive Income Loss Net Of Tax

us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value-13131-11640-11801-11535-10923-11275-10417-10003-9402-10235-9321-9164-10181-10594-11036-8214-8891-9520-9522-9170-8521-8557-7316-3467-3152-3390-3271-6383-6465-6155-5953-5653-6008-3622-4129-1211-952-2056-3440552
Percentage of AccumulatedOtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets-7.9-6.9-6.9-7.4-7.0-7.1-6.2-6.1-5.70.0-5.4-5.3-6.0-6.3-6.4-4.6-5.2-5.8-5.7-5.4-5.3-5.3-4.3-2.0-1.8-2.0-1.9-3.6-3.6-3.3-3.2-3.1-3.3-2.0-2.2-0.6-0.5-1.1-1.80.3

Treasury Stock Value

us-gaap:TreasuryStockValue



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value111010110801110795110786110781101610965749546395460894258942189416894148436484346843138431379252792597909879100730217182070535692046792363272595154483240121367033486333519318012858626471242152271221632
Percentage of TreasuryStockValue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets66.766.265.070.971.363.957.557.958.052.051.953.053.049.247.349.451.747.346.449.249.243.141.940.940.339.536.033.223.921.620.119.118.116.914.613.512.411.610.2

Minority Interest

us-gaap:MinorityInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value312303293357352351346346358348340326311296294297279278286286283321317323299313385430577418412414421431483482466452432
Percentage of MinorityInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of Assets0.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.20.30.20.20.20.20.20.20.20.20.20.2

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value31333769451026111698473852591983674215895972165147135024409068553984463408729352241277452614642-6360
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax26.029.735.619.712.933.939.515.449.212.443.812.733.641.634.56.341.136.132.025.916.618.031.428.1-38.4

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value-71-2833-6760-19027550-764-29049667-47794772-31074355-2224-5243-21056592-1514-2535-1507-98-109304518997259394
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.6-22.3-53.3-14.357.6-5.5-21.874.9-34.937.3-22.833.5-15.8-43.4-17.860.7-11.5-20.5-11.8-0.9-81.02.95.44.456.7

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value-2200-24403273-851-8467-6407-1406-10720-3385-4921-2228-7014-1109-267-1875-6982-2926-2887-2040-2133434-3507-6250-6404-3211
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-18.3-19.225.8-6.4-64.5-45.8-10.6-83.1-24.7-38.5-16.3-53.9-7.9-2.2-15.8-64.3-22.3-23.4-16.0-18.83.2-22.8-37.3-38.8-19.4

Net Cash Provided By Used In Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value31333769451026111698473852591983674215895972165147135024409068553984463408729352241277452614642-6360
Percentage of NetCashProvidedByUsedInOperatingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax26.029.735.619.712.933.939.515.449.212.443.812.733.641.634.56.341.136.132.025.916.618.031.428.1-38.4

Net Income Loss

us-gaap:NetIncomeLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value3401-336768050463884-39341143872356112274284030733121860132020193016-172213026262376122826662912232925901409527503208325317941439373826102610222286624752026
Percentage of NetIncomeLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.3-2.660.638.029.6-2.830.928.827.689.621.623.824.46.310.115.423.2-1.217.622.221.99.421.622.820.520.5108.620.423.021.611.68.621.715.415.813.55.414.412.2

Profit Loss

us-gaap:ProfitLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value3410-326768450563889-38341223879357012289285830783130866131920353026-169213926352381123626722921233825991413427653214326018031450374926182618223487124852035
Percentage of ProfitLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.4-2.660.638.129.6-2.731.028.827.789.721.723.924.56.410.115.523.3-1.217.722.221.99.421.622.920.620.6108.920.523.021.711.78.721.815.415.913.55.414.512.3

us-gaap:StatementEquityComponents

us-gaap:NoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value910410611879
Percentage of ProfitLoss0.3-3.10.10.20.2-2.90.20.20.3
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax0.10.10.00.10.00.10.10.10.1
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:NoncontrollingInterest0.00.00.00.00.00.00.00.00.0

us-gaap:Parent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value3401-336768050463884-393411438723561
Percentage of ProfitLoss99.7103.199.999.899.9102.699.899.899.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.3-2.660.638.029.6-2.830.928.827.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:Parent0.00.00.00.00.00.00.00.00.0

us-gaap:RetainedEarnings



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value3401-336768050463884-393411438723561
Percentage of ProfitLoss99.7103.199.999.899.9102.699.899.899.7
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax28.3-2.660.638.029.6-2.830.928.827.6
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax us-gaap:RetainedEarnings0.00.00.00.00.00.00.00.00.0

Depreciation Depletion And Amortization

Increase Decrease In Inventories

Net Cash Provided By Used In Investing Activities

us-gaap:NetCashProvidedByUsedInInvestingActivities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value-71-2833-6760-19027550-764-29049667-47794772-31074355-2224-5243-21056592-1514-2535-1507-98-109304518997259394
Percentage of NetCashProvidedByUsedInInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-0.6-22.3-53.3-14.357.6-5.5-21.874.9-34.937.3-22.833.5-15.8-43.4-17.860.7-11.5-20.5-11.8-0.9-81.02.95.44.456.7

Payments To Acquire Property Plant And Equipment

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value463672565479460685547386700358689301611289258239354275278292202254598250305
Percentage of PaymentsToAcquirePropertyPlantAndEquipment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Net Cash Provided By Used In Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value-2200-24403273-851-8467-6407-1406-10720-3385-4921-2228-7014-1109-267-1875-6982-2926-2887-2040-2133434-3507-6250-6404-3211
Percentage of NetCashProvidedByUsedInFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0
Percentage of RevenueFromContractWithCustomerExcludingAssessedTax-18.3-19.225.8-6.4-64.5-45.8-10.6-83.1-24.7-38.5-16.3-53.9-7.9-2.2-15.8-64.3-22.3-23.4-16.0-18.83.2-22.8-37.3-38.8-19.4

Proceeds From Issuance Of Long Term Debt

us-gaap:ProceedsFromIssuanceOfLongTermDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272014-12-312014-09-282014-06-292014-03-302013-03-312012-04-01
Value12410004942049740152735945000004491026240
Percentage of ProceedsFromIssuanceOfLongTermDebt100.00.00.00.0100.00.0100.00.0100.0100.0100.00.00.00.00.00.0100.00.0100.00.0

Repayments Of Long Term Debt

us-gaap:RepaymentsOfLongTermDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value2181100045123513004462035516801253337215360103002131834075223350038789
Percentage of RepaymentsOfLongTermDebt100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.00.0100.00.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Payments For Repurchase Of Common Stock

us-gaap:PaymentsForRepurchaseOfCommonStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-07-132015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-03
Value000088655030110560630500005000052001600600011991281132311974626165932111430
Percentage of PaymentsForRepurchaseOfCommonStock0.00.00.00.0100.0100.0100.0100.00.0100.00.0100.00.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Repayments Of Long Term Debt

us-gaap:RepaymentsOfLongTermDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value2181100045123513004462035516801253337215360103002131834075223350038789
Percentage of RepaymentsOfLongTermDebt100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.00.0100.00.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0
Percentage of LongTermDebtAndCapitalLeaseObligations0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0

Debt Instrument Interest Rate Stated Percentage

Effective Income Tax Rate Continuing Operations

us-gaap:EffectiveIncomeTaxRateContinuingOperations



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value0.122-0.056000000000000010.284-0.2210.1-0.040000000000000010.0160.1430.135-0.93599999999999990.2030.1940.208-0.0239999999999999940.1770.1560.15-0.012000000000000010.210.2560.2290.0080000000000000070.2540.270.2040.2760.3330.296-0.040.2880.2940.0070000000000000060.3370.2970.2990.2870.3950.3750.36
Percentage of EffectiveIncomeTaxRateContinuingOperations100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number

Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period

Share Based Compensation

us-gaap:ShareBasedCompensation



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value642706419918526730318224521815914318114118516216214313814318913072122138
Percentage of ShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Deferred Tax Liabilities

Deferred Tax Assets Net

Unrecognized Tax Benefits

Deferred Tax Assets Valuation Allowance

Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions

Operating Lease Right Of Use Asset

Cash And Cash Equivalents Period Increase Decrease

Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312015-12-31
Value219613502846183720181225365828112416143128582661413126663707
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

Proceeds From Repayments Of Short Term Debt

pfe:AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value885103212121184118312531253119111961187117712081186112296896110069809378729409499721001111711171140123412281291142013891384
Percentage of AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:AssetWriteOffsAndAssetImpairmentCharges



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-31
Value4527294623155331047730835467146255822311111722552137237
Percentage of AssetWriteOffsAndAssetImpairmentCharges100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:BusinessAlignmentCosts



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value0-587119581
Percentage of BusinessAlignmentCosts0.0100.0100.0100.0100.0100.0

pfe:BusinessCombinationAcquisitionRelatedCostsTransactionCosts



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302012-09-302012-07-012011-12-312011-10-022011-07-032011-07-032011-04-032010-07-042010-04-04
Value3-265001000-14612135436245364150000012513131049
Percentage of BusinessCombinationAcquisitionRelatedCostsTransactionCosts100.0100.0100.00.00.0100.00.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.00.00.0100.0100.0100.0100.0100.0100.0100.0

pfe:DeconsolidationGainLossAmountNetOfCashConveyed



Period End2020-03-292019-12-312019-03-312018-12-31
Value6000
Percentage of DeconsolidationGainLossAmountNetOfCashConveyed100.00.00.00.0

pfe:DefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeLossNetActuarialGainLossTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value8-70-1023-2-138383467716114366-402403855308-449109-1326302513137743
Percentage of DefinedBenefitPlanAmountsRecognizedinOtherComprehensiveIncomeLossNetActuarialGainLossTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-31
Value121813841553152815451641161415671574155515491425142412721201126013311326142414561489
Percentage of DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:ImplementationCosts



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value2449404226644844397757623113878646268424548897376324746391115663221010
Percentage of ImplementationCosts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncomeStatementLocation

us-gaap:CostOfSales



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-01
Value101814171326212016412636151034638433823281326242261656194
Percentage of ImplementationCosts41.736.735.040.550.040.643.845.541.053.245.658.148.474.659.059.469.455.954.862.227.129.232.928.918.834.010.915.417.17.1

us-gaap:ResearchAndDevelopmentExpense



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value063941797612911788561238121216111734737481010
Percentage of ImplementationCosts0.012.27.521.415.426.618.815.915.415.615.817.722.65.810.37.89.71.54.86.716.713.516.421.134.42.115.27.742.366.176.245.5100.0

us-gaap:SellingGeneralAndAdministrativeExpenses



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value1525231692117161725221592523201227161326513638155030
Percentage of ImplementationCosts62.551.057.538.134.632.835.436.443.632.538.624.229.018.129.531.219.439.738.128.954.257.349.350.046.90.063.8

pfe:IncomeLossFromCollaborationsLicensingAgreementsAndSalesOfCompoundProductRights



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-02
Value115442022823313917414254783747
Percentage of IncomeLossFromCollaborationsLicensingAgreementsAndSalesOfCompoundProductRights100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:IncomeLossFromContinuingOperationsAvailableToCommonStockholdersBasic



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value3401-337767650453883-39441033871356212273283930713121843132020183016-16921212625237012492669291122562582356527383103318717941481242325802513221285024432004
Percentage of IncomeLossFromContinuingOperationsAvailableToCommonStockholdersBasic100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:IncomeLossFromContinuingOperationsAvailableToCommonStockholdersdiluted



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value3401-337767650463884-39441033872356212274284030713121842132020183016-16921212626237112492670291222562626258235652607
Percentage of IncomeLossFromContinuingOperationsAvailableToCommonStockholdersdiluted100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:IncomeLossFromEquityMethodInvestmentsNetExcessBasisAmortization



Period End2020-03-292019-03-31
Value-330
Percentage of IncomeLossFromEquityMethodInvestmentsNetExcessBasisAmortization100.00.0

pfe:InterestPaidInterestRateHedges



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-03
Value-1136-6-39-3366-3320-163218-27
Percentage of InterestPaidInterestRateHedges100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

pfe:OtherComprehensiveIncomeLossNonDerivativeNetInvestmentHedgeGainLossbeforeReclassificationandTax

pfe:ForeignCurrencyLongTermDebt, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value45-5379383817
Percentage of OtherComprehensiveIncomeLossNonDerivativeNetInvestmentHedgeGainLossbeforeReclassificationandTax100.0100.0100.0100.0100.0100.0

pfe:ForeignCurrencyShortTermBorrowings, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value8-314535188
Percentage of OtherComprehensiveIncomeLossNonDerivativeNetInvestmentHedgeGainLossbeforeReclassificationandTax17.858.557.092.147.447.1

us-gaap:IncomeStatementLocation

pfe:OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossReclassificationBeforeTax

pfe:OtherIncomeDeductionsAndCostOfSales



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value2333674286113256
Percentage of OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossReclassificationBeforeTax100.0100.0100.0100.0100.0100.0

pfe:OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossbeforeReclassificationandTax



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value83-19642940459304
Percentage of OtherComprehensiveIncomeLossNonDerivativesAndDerivativesGainLossbeforeReclassificationandTax100.0100.0100.0100.0100.0100.0

us-gaap:IncomeStatementLocation

pfe:OtherComprehensiveIncomeLossNonDerivativesAndDerivativesOtherGainLossReclassificationBeforeTax

pfe:OtherIncomeDeductionsAndCostOfSales



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value0-10010
Percentage of OtherComprehensiveIncomeLossNonDerivativesAndDerivativesOtherGainLossReclassificationBeforeTax0.0100.00.00.0100.00.0

pfe:OtherComprehensiveIncomeLossNonDerivativesAndDerivativesOtherGainLossbeforeReclassificationandTax



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value-1000000.00.0-1000000.01000000.0-2000000.00.0
Percentage of OtherComprehensiveIncomeLossNonDerivativesAndDerivativesOtherGainLossbeforeReclassificationandTax100.00.0100.0100.0100.00.0

pfe:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value01-1001-16-61-1002-22-12-2101-27-5-1-1
Percentage of OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodTax0.0100.0100.00.00.0100.0100.0100.0100.0100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0

pfe:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value13-3-10-101-22-10-16-6-1-5012080014-2
Percentage of OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax100.0100.0100.0100.00.0100.00.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.00.0100.0100.00.0100.00.00.0100.0100.0100.0

pfe:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetUnamortizedGainLossArisingDuringPeriodTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value-4121-85-11-11-2720-73317-5-31-1491-379-1-37-65-3-5123323
Percentage of OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetUnamortizedGainLossArisingDuringPeriodTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetUnamortizedGainLossArisingDuringPeriodbeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value-1638-42-4123-43-49-10786347680-45-144-6957-38-791029-158-172-429176428
Percentage of OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetUnamortizedGainLossArisingDuringPeriodbeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:OtherComprehensiveIncomeLossSettlementAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansforNetGainLossBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value-53000000.0-234000000.0-38000000.0-2000000.00.0-34000000.0-42000000.0-30000000.0-37000000.0-28000000.0-38000000.01000000.0-52000000.0-51000000.0-28000000.0-22000000.0-26000000.0-573000000.0-36000000.0-22000000.0-40000000.0-43000000.0-19000000.0-18000000.0-21000000.0-28000000.0-54000000.0
Percentage of OtherComprehensiveIncomeLossSettlementAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansforNetGainLossBeforeTax100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:OtherComprehensiveIncomeLossSettlementAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansforNetGainLossTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value-9-55-900-8-10-7-9-12-224-12-18-10-8-9-202-12-8-15-14-6-7-852-18
Percentage of OtherComprehensiveIncomeLossSettlementAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansforNetGainLossTax100.0100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:OtherNonoperatingIncomeExpenseNet



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value13294-242729148239115-513719116490-20255-66122-333-5015-34152108571577-104
Percentage of OtherNonoperatingIncomeExpenseNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess



Period End2020-03-292019-03-31
Value416-5941
Percentage of PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess100.0100.0

pfe:PaymentsforRestructuringOtherRestructuringAndRestructuringTranslationAdjustment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-31
Value2752241461521693598210010517927517526431282162307
Percentage of PaymentsforRestructuringOtherRestructuringAndRestructuringTranslationAdjustment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RestructuringCostAndReserve

pfe:AssetImpairments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-31
Value31783-992821226424971451985617
Percentage of PaymentsforRestructuringOtherRestructuringAndRestructuringTranslationAdjustment11.334.82.1-5.95.378.614.62.061.013.435.30.617.063.56.13.75.5

us-gaap:EmployeeSeverance



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-31
Value243124128158145606485731591421652148470127266
Percentage of PaymentsforRestructuringOtherRestructuringAndRestructuringTranslationAdjustment88.455.487.7103.985.816.778.085.069.588.851.694.381.126.985.478.486.6

us-gaap:OtherRestructuring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-31
Value1221531517614-33-436953063025
Percentage of PaymentsforRestructuringOtherRestructuringAndRestructuringTranslationAdjustment0.49.810.32.08.94.77.314.0-31.4-2.213.15.11.99.67.318.58.1

pfe:PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-31
Value248-9311616215195174692-81986-63853-187-38-32874-9842599-54
Percentage of PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:PercentageChangeInRevenue



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-022017-04-022016-10-022016-07-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-0.08-0.05-0.020.020.010.040.010.01-0.02-0.020.080.11-0.02-0.07-0.04-0.02-0.02-0.09-0.02-0.07-0.09-0.16-0.09-0.070.07-0.01
Percentage of PercentageChangeInRevenue100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementGeographical

country:US



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-022017-04-022016-10-022016-07-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-0.08-0.080.02-0.02-0.03-0.02-0.050.00.00.00.170.270.150.020.04-0.07-0.04-0.130.0-0.04-0.1-0.18-0.15-0.15-0.03-0.09
Percentage of PercentageChangeInRevenue100.0160.0-100.0-100.0-300.0-50.0-500.00.0-0.0-0.0212.5245.5-750.0-28.6-100.0350.0200.0144.4-0.057.1111.1112.5166.7214.3-42.9900.0

pfe:DevelopedEurope



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-022017-04-022016-10-022016-07-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-0.08-0.04-0.050.00.030.10.04-0.02-0.12-0.14-0.040.03-0.18-0.21-0.170.020.030.0-0.01-0.11-0.14-0.26-0.17-0.080.080.05
Percentage of PercentageChangeInRevenue100.080.0250.00.0300.0250.0400.0-200.0600.0700.0-50.027.3900.0300.0425.0-100.0-150.0-0.050.0157.1155.6162.5188.9114.3114.3-500.0

pfe:DevelopedRestOfWorld



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-022017-04-022016-10-022016-07-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-0.05-0.03-0.030.050.010.05-0.06-0.05-0.060.030.130.1-0.17-0.16-0.14-0.09-0.12-0.15-0.17-0.17-0.17-0.10.020.030.21-0.01
Percentage of PercentageChangeInRevenue62.560.0150.0250.0100.0125.0-600.0-500.0300.0-150.0162.590.9850.0228.6350.0450.0600.0166.7850.0242.9188.962.5-22.2-42.9300.0100.0

pfe:EmergingMarkets



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-022017-04-022016-10-022016-07-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-0.10.01-0.050.080.080.140.20.10.060.03-0.04-0.09-0.06-0.030.030.070.05-0.040.040.010.05-0.020.070.060.210.1
Percentage of PercentageChangeInRevenue125.0-20.0250.0400.0800.0350.02000.01000.0-300.0-150.0-50.0-81.8300.042.9-75.0-350.0-250.044.4-200.0-14.3-55.612.5-77.8-85.7300.0-1000.0

pfe:RestructuringAssetImpairmentCharges



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value31783-9928212-626410102497271614519856179136500
Percentage of RestructuringAssetImpairmentCharges100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0

pfe:RestructuringChargesAcquisitionRelatedCostsandImplementationCosts



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value117515420-5992987186131131204245153202930655433252545647159127250108259164778323
Percentage of RestructuringChargesAcquisitionRelatedCostsandImplementationCosts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:RestructuringChargesAndAcquisitionRelatedCosts



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value69452365-11546872854443110149701577365313161414255818660130-1981582331831383021905964601101479478894499885706
Percentage of RestructuringChargesAndAcquisitionRelatedCosts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

pfe:StockIssuedAndRedeemedDuringPeriodSharesConversionAndRedemptionofStock

us-gaap:PreferredStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value000000000
Percentage of StockIssuedAndRedeemedDuringPeriodSharesConversionAndRedemptionofStock100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

pfe:StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock

us-gaap:AdditionalPaidInCapital



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value110111111
Percentage of StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock100.0100.00.0100.0100.0100.0100.0100.0100.0

us-gaap:PreferredStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-30
Value1101011
Percentage of StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock100.0100.00.0100.00.0100.0100.0

us-gaap:TreasuryStock



Period End2020-03-29
Value0
Percentage of StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock0.0

us-gaap:FiniteLivedIntangibleAssetsByMajorClass

us-gaap:AmortizationOfIntangibleAssets

us-gaap:FiniteLivedIntangibleAssets



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-31
Value89711001200120012001300130012001200120012001200120011009889771000100095088410001000100010001100110012001300
Percentage of AmortizationOfIntangibleAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecurities

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount

us-gaap:StockOption



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-022017-04-022016-10-022016-07-032016-04-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-09-29
Value331253247474836458655563444444343
Percentage of AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AssetImpairmentCharges



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-03-312012-04-012011-12-312011-04-032010-04-04
Value0265528101503075-1310252130012367133816131160633250111243013722051365042516559
Percentage of AssetImpairmentCharges0.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BusinessCombinationIntegrationRelatedCosts



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value103021729365882685281735010114174139871174842132719151838333987108100163187201199179231211208
Percentage of BusinessCombinationIntegrationRelatedCosts100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BusinessExitCosts1



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-01
Value020-131319143-351042102931428304614436421213688
Percentage of BusinessExitCosts10.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-02
Value846-14951008-180792-2432846985-14281465
Percentage of CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1

us-gaap:ForeignExchangeContract, us-gaap:DesignatedAsHedgingInstrument, us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value000001
Percentage of ChangeInUnrealizedGainLossOnFairValueHedgingInstruments10.00.00.00.00.0100.0

us-gaap:InterestRateContract, us-gaap:DesignatedAsHedgingInstrument, us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value386-291378329367-195
Percentage of ChangeInUnrealizedGainLossOnFairValueHedgingInstruments10.00.00.00.00.0-19500.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1

us-gaap:ForeignExchangeContract, us-gaap:DesignatedAsHedgingInstrument, us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value00000-1
Percentage of ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge10.00.00.00.00.0100.0

us-gaap:InterestRateContract, us-gaap:DesignatedAsHedgingInstrument, us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value-386291-378-329-367195
Percentage of ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge10.00.00.00.00.0-19500.0

us-gaap:DeconsolidationGainOrLossAmount



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value6-18087000
Percentage of DeconsolidationGainOrLossAmount100.0100.0100.00.00.00.0

us-gaap:DeferredIncomeTaxExpenseBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value109-14532227-100-60-1231-474294-265138635-20414518-142-41-446-87508345927-404-429-120840
Percentage of DeferredIncomeTaxExpenseBenefit100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAmortizationOfGainsLosses

country:US, us-gaap:NonqualifiedPlan, us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-4000000.0-4000000.0-2000000.0-2000000.0-2000000.0-3000000.0-3000000.0-3000000.0-4000000.0-13000000.0-12000000.0-12000000.0-13000000.0-10000000.0-9000000.0-9000000.0
Percentage of DefinedBenefitPlanAmortizationOfGainsLosses100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-32000000.0-37000000.0-37000000.0-37000000.0-37000000.0-30000000.0-30000000.0-30000000.0-30000000.0-91000000.0-91000000.0-97000000.0-115000000.0-98000000.0-99000000.0-99000000.0
Percentage of DefinedBenefitPlanAmortizationOfGainsLosses800.0925.01850.01850.01850.01000.01000.01000.0750.0700.0758.3808.3884.6980.01100.01100.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType

us-gaap:ForeignPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-31000000.0-19000000.0-20000000.0-20000000.0-20000000.0-24000000.0-25000000.0-26000000.0-26000000.0-30000000.0-29000000.0-28000000.0-28000000.0-23000000.0-23000000.0-24000000.0
Percentage of DefinedBenefitPlanAmortizationOfGainsLosses775.0475.01000.01000.01000.0800.0833.3866.7650.0230.8241.7233.3215.4230.0255.6266.7

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value0.0-1000000.00.0-1000000.0-1000000.0-2000000.0-2000000.0-2000000.0-2000000.0-8000000.0-8000000.0-8000000.0-8000000.0-9000000.0-9000000.0-7000000.0
Percentage of DefinedBenefitPlanAmortizationOfGainsLosses-0.025.0-0.050.050.066.766.766.750.061.566.766.761.590.0100.077.8

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanAmortizationOfPriorServiceCostCredit

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-1-1-1-1-110000012111
Percentage of DefinedBenefitPlanAmortizationOfPriorServiceCostCredit100.0100.0100.0100.0100.0100.00.00.00.00.00.0100.0100.0100.0100.0100.0

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-43-41-43-45-45-43-45-45-45-45-45-46-46-47-45-41
Percentage of DefinedBenefitPlanAmortizationOfPriorServiceCostCredit4300.04100.04300.04500.04500.0-4300.00.00.00.00.00.0-4600.0-2300.0-4700.0-4500.0-4100.0

us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-31-394-3110037-627158141175-36-1124261-14531558520387723118365-3923127475915025632545-361253134138
Percentage of DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeLossNetGainLossBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value459884646535053515248525262-48-484212951-46446-716183231417242264-303340-31
Percentage of DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanContributionsByEmployer

country:US, us-gaap:NonqualifiedPlan, us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-01
Value13222232871111984
Percentage of DefinedBenefitPlanContributionsByEmployer100.0100.0100.0100.0100.0100.0100.0100.0

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-02-282018-04-012017-01-31
Value33341005005001000
Percentage of DefinedBenefitPlanContributionsByEmployer2.313.613.014.31.40.00.0595.20.00.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType

us-gaap:ForeignPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-31
Value467228864435903726
Percentage of DefinedBenefitPlanContributionsByEmployer34.8327.3121.7307.162.0318.2473.744.00.0

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-31
Value453436382937373725
Percentage of DefinedBenefitPlanContributionsByEmployer34.1154.5156.5135.740.8336.4194.744.00.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedReturnOnPlanAssets

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value252223222223223257259261263246248252259237239240
Percentage of DefinedBenefitPlanExpectedReturnOnPlanAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType

us-gaap:ForeignPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value78787980808689939289878584909598
Percentage of DefinedBenefitPlanExpectedReturnOnPlanAssets31.035.035.635.935.933.534.435.635.036.235.133.732.438.039.740.8

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value9888899999999988
Percentage of DefinedBenefitPlanExpectedReturnOnPlanAssets3.63.63.63.63.63.53.53.43.43.73.63.63.53.83.33.3

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanInterestCost

country:US, us-gaap:NonqualifiedPlan, us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value10101212121514141313131314131811
Percentage of DefinedBenefitPlanInterestCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value131157157157157148149150151156157159162160218134
Percentage of DefinedBenefitPlanInterestCost1310.01570.01308.31308.31308.3986.71064.31071.41161.51200.01207.71223.11157.11230.81211.11218.2

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType

us-gaap:ForeignPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value42535354545252555452525050555860
Percentage of DefinedBenefitPlanInterestCost420.0530.0441.7450.0450.0346.7371.4392.9415.4400.0400.0384.6357.1423.1322.2545.5

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value13181919191818181822232323243322
Percentage of DefinedBenefitPlanInterestCost130.0180.0158.3158.3158.3120.0128.6128.6138.5169.2176.9176.9164.3184.6183.3200.0

us-gaap:IncomeStatementLocation

us-gaap:DefinedBenefitPlanNetPeriodicBenefitCost

us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-02
Value244946434129322635174
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

country:US, us-gaap:NonqualifiedPlan, us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value52224117202820213339393553323931
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost216.7550.0455.6425.0333.365.148.872.4103.1150.0111.43500.071.60.00.00.0

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-76196-25-27-28-42-40-49-5890996912412817073
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost-316.74900.0-277.8-675.0-466.7-97.7-97.6-169.0-181.2346.2282.96900.0167.60.00.00.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType

us-gaap:ForeignPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value32273725252317212441353735342727
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost133.3675.0411.1625.0416.753.541.572.475.0157.7100.03700.047.30.00.00.0

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-30-22-78-23-23-22-26-32-31-18-17-19-21-23-9-11
Percentage of DefinedBenefitPlanNetPeriodicBenefitCost-125.0-550.0-866.7-575.0-383.3-51.2-63.4-110.3-96.9-69.2-48.6-1900.0-28.40.00.00.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1

country:US, us-gaap:NonqualifiedPlan, us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-38-6-2200-2-3-5-17-7-7-4-21-5-7-6
Percentage of DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1100.0100.0100.00.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-14-227-1-2-1-29-38-25-20-21-307-31-38-21-16
Percentage of DefinedBenefitPlanRecognizedNetGainLossDueToSettlements136.83783.34.50.00.01450.01266.7500.0117.6300.0428.6-175.0147.6760.0300.0266.7

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType

us-gaap:ForeignPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value-1-4-1200-4000-10-2-1-7-10
Percentage of DefinedBenefitPlanRecognizedNetGainLossDueToSettlements12.666.754.50.00.0200.0-0.0-0.0-0.014.3-0.050.04.8140.014.3-0.0

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value00100000000000000
Percentage of DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1-0.0-0.0-45.50.00.0-0.0-0.0-0.0-0.0-0.0-0.0-0.0-0.0-0.0-0.0-0.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanServiceCost

country:US, us-gaap:NonqualifiedPlan, us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value0000000006666455
Percentage of DefinedBenefitPlanServiceCost0.00.00.00.00.00.00.00.00.0100.0100.0100.0100.0100.0100.0100.0

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value00000000067676768646962
Percentage of DefinedBenefitPlanServiceCost0.00.00.00.00.00.00.00.00.01116.71116.71116.71133.31600.01380.01240.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType

us-gaap:ForeignPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value36313131323233343744444241394143
Percentage of DefinedBenefitPlanServiceCost0.00.00.00.00.00.00.00.00.0733.3733.3700.0683.3975.0820.0860.0

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-03
Value1099991010101010101111101110
Percentage of DefinedBenefitPlanServiceCost0.00.00.00.00.00.00.00.00.0166.7166.7183.3183.3250.0220.0200.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanSpecialTerminationBenefits

country:US, us-gaap:NonqualifiedPlan, us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value-131-5-3-6-10000
Percentage of DefinedBenefitPlanSpecialTerminationBenefits100.0100.0100.0100.0100.0100.00.00.00.0

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value08-3-10-6000
Percentage of DefinedBenefitPlanSpecialTerminationBenefits-0.025.860.033.3-0.060.00.00.00.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType

us-gaap:ForeignPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value000001000
Percentage of DefinedBenefitPlanSpecialTerminationBenefits-0.00.0-0.0-0.0-0.0-10.00.00.00.0

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value04-1-10-2000
Percentage of DefinedBenefitPlanSpecialTerminationBenefits-0.012.920.033.3-0.020.00.00.00.0

us-gaap:IncomeStatementLocation

us-gaap:DerivativeGainLossOnDerivativeNet

us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value-5929-77-4-120-2015062-552434-9-143-5118-48-25049-75-381123135-185-100
Percentage of DerivativeGainLossOnDerivativeNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet

us-gaap:ForeignExchangeContract, us-gaap:Nondesignated, us-gaap:OtherNonoperatingIncomeExpense



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value-5929-77-120-20150
Percentage of DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet100.0100.0100.0100.0100.0100.0

us-gaap:DividendsCommonStockCash



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value712106200639946820481977397065
Percentage of DividendsCommonStockCash100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:Parent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value712106200639946820481977397065
Percentage of DividendsCommonStockCash100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetainedEarnings



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value712106200639946820481977397065
Percentage of DividendsCommonStockCash100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-02
Value-159-13-40120-10155-1421
Percentage of EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents100.0100.0100.0100.0100.00.0100.0100.0100.0100.0

us-gaap:EquitySecuritiesFvNiGainLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-01
Value-2553016361111269423211811345
Percentage of EquitySecuritiesFvNiGainLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EquitySecuritiesFvNiRealizedGainLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value1912365199-54-1919
Percentage of EquitySecuritiesFvNiRealizedGainLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value-2742893311061074021398
Percentage of EquitySecuritiesFvNiUnrealizedGainLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName

pfe:Allogene



Period End2020-03-292019-03-31
Value-13443
Percentage of EquitySecuritiesFvNiUnrealizedGainLoss48.940.6

us-gaap:LitigationCase, us-gaap:ProductOrService, us-gaap:LitigationStatus

us-gaap:GainContingencyPatentsFoundNotInfringedUponNumber

pfe:HospiraVersusParSterilProductsLLCGlandPharmaLimitedAndJiangsuHengruiMedicineCo., pfe:PrecedexPremix, us-gaap:SettledLitigation



Period End2020-03-29
Value3.0
Percentage of GainContingencyPatentsFoundNotInfringedUponNumber100.0

us-gaap:GainLossOnDispositionOfAssets1



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-01
Value-1-23201524157-8113
Percentage of GainLossOnDispositionOfAssets1100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:GainLossRelatedToLitigationSettlement



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032014-12-312014-09-282014-06-292013-09-292013-06-302012-09-302012-07-01
Value-10-470-64-15-4-227-378819-46-183-3-8-1640-261-274000-9135100
Percentage of GainLossRelatedToLitigationSettlement100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.00.0100.0100.00.00.0

us-gaap:GainsLossesOnExtinguishmentOfDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-11-212016-11-30
Value0000-138000-3-999-312-312
Percentage of GainsLossesOnExtinguishmentOfDebt0.00.00.00.0100.00.00.00.0100.0100.0100.0100.0

us-gaap:GoodwillOtherIncreaseDecrease



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-31
Value-151-46-64-13576-2203-221441-126136-786
Percentage of GoodwillOtherIncreaseDecrease100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-31
Value-122-37-52-470
Percentage of GoodwillOtherIncreaseDecrease80.880.481.234.80.0

us-gaap:OperatingSegments, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-31
Value-30-9-12-120
Percentage of GoodwillOtherIncreaseDecrease19.919.618.88.90.0

us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-07-012016-12-312016-10-022016-07-032015-12-312015-09-272014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-07-03
Value13027900101303110212664116016340242011418548939549453395320
Percentage of ImpairmentOfIntangibleAssetsExcludingGoodwill100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, us-gaap:DevelopedTechnologyRights, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-31
Value4000040
Percentage of ImpairmentOfIntangibleAssetsExcludingGoodwill30.80.00.00.030.8

us-gaap:ProductOrService, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass, us-gaap:Subsegments

pfe:GeneTherapies, us-gaap:InProcessResearchAndDevelopment, pfe:PfizersWorldwideResearchDevelopmentAndMedical



Period End2020-03-29
Value90
Percentage of ImpairmentOfIntangibleAssetsExcludingGoodwill69.2

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value004000110-1102017010-3815-22-3073111055941046679-431315309710153121
Percentage of IncomeLossFromDiscontinuedOperationsNetOfTax0.00.0100.00.00.00.0100.00.0100.0100.00.0100.00.0100.00.0100.00.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-01
Value004000110-1102017010-3815-22-30731110534143225260
Percentage of IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity0.00.0100.00.00.00.0100.00.0100.0100.00.0100.00.0100.00.0100.00.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-04-04
Value0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.010.01.50.00.010.010.010.00.170.010.00.0
Percentage of IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0100.00.0100.00.0100.0100.0100.00.0100.0100.00.00.0

us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-04-04
Value0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.010.01.480.00.010.010.010.00.170.010.00.0
Percentage of IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0100.00.0100.00.0100.0100.0100.00.0100.0100.00.00.0

us-gaap:IncreaseDecreaseInOperatingCapital



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-04-012017-04-022016-04-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-03-312012-04-012011-04-032010-04-04
Value1581-148035533498-809271522252261-585-61879-430858109133931558-52211980
Percentage of IncreaseDecreaseInOperatingCapital100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InterestPaidNet



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-04-03
Value472341437424385343244259417216274382140248582332221333635361433508687
Percentage of InterestPaidNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:InterestRevenueExpenseNet



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value-356000000.0-375000000.0-348000000.0-330000000.0-295000000.0-277000000.0-228000000.0-245000000.0-233000000.0-213000000.0-220000000.0-218000000.0-228000000.0-184000000.0-168000000.0-170000000.0-193000000.0-195000000.0-157000000.0-159000000.0-216000000.0-232000000.0-235000000.0-239000000.0-229000000.0-235000000.0-246000000.0
Percentage of InterestRevenueExpenseNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName

us-gaap:InvestmentIncomeDividend

pfe:ViiV



Period End2020-03-292019-09-292019-03-312018-09-30
Value77436491
Percentage of InvestmentIncomeDividend100.0100.0100.0100.0

us-gaap:InvestmentIncomeInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value344160596693828077116999481113123122113139121119931221081049211294
Percentage of InvestmentIncomeInterest100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value01-2805070
Percentage of MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders0.0100.0100.0100.00.0100.00.0100.00.0

us-gaap:NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-02
Value-67174-19-51-40-57-65-84-822028-8
Percentage of NetPeriodicDefinedBenefitsExpenseReversalOfExpenseExcludingServiceCostComponent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-02
Value-21-127-41-10-1682-1338-44-37220-496-31-8020-51-412-14195-31-156-39-118201
Percentage of OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value-12721282-468-485324-292-567-699758-236878247228-181441851467-940-535-327-1308-1719-431233-75-21-755-292153-198126309561589
Percentage of OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossBeforeReclassificationAndTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-01
Value-45000000.0-44000000.0-44000000.0-46000000.0-46000000.0-44000000.0-46000000.0-46000000.0-46000000.0-46000000.0-46000000.0-46000000.0-45000000.0-46000000.0-45000000.0-41000000.0-41000000.0-45000000.0-46000000.0-34000000.0-35000000.0-18000000.0-19000000.0-18000000.0-18000000.0-16000000.0-13000000.0-16000000.0-20000000.0-17000000.0
Percentage of OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-01
Value-11-10-11-11-11-6-11-11-11-17-17-17-17-17-17-15-15-17-367-13-7-7-7-7-5-6-6-7-6
Percentage of OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-36-398195173112-231-47656106124287-481149124339-36294299-81-148-185-949-17170-2262897-5116
Percentage of OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-5-5127914-29-47-5-121148-56262143-45725-32-4-25-15-2-3032117-321-153
Percentage of OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-1867224-190-669372-1008-361-440352-201938258474-3110794669-44-94-721263-1152-4870-238258-138121-144-29427-2608710-4781074
Percentage of OtherComprehensiveIncomeLossBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-02
Value-482-57122-2564-108-13437-69126-297
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-02
Value-118-1828-574-27779-9-13-1-89
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-02
Value-501235150-176267-16222127-114139-50-90
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:ForeignExchangeContract, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value-529202131210-67183
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax105.686.087.378.7418.882.4

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-02
Value-1334631-5359-18358-44228-1
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-02
Value-19292298126392235-310-44127-56208
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:ForeignExchangeContract, us-gaap:DesignatedAsHedgingInstrument, pfe:OtherIncomeDeductionsAndCostOfSales



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value-46260720922198
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax242.189.024.179.523.984.3

us-gaap:ForeignExchangeContract, us-gaap:DesignatedAsHedgingInstrument, us-gaap:CostOfSales



Period End2020-03-292019-03-31
Value7044
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax-368.416.7

us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-02
Value-15633455928-727552988
Percentage of OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation, us-gaap:IncomeStatementLocation

us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax

us-gaap:ForeignExchangeContract, us-gaap:CashFlowHedging, us-gaap:DesignatedAsHedgingInstrument, pfe:OtherIncomeDeductionsAndCostOfSales



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value273222546936
Percentage of OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax100.0100.0100.0100.0100.0100.0

us-gaap:ForeignExchangeContract, us-gaap:NetInvestmentHedging, us-gaap:DesignatedAsHedgingInstrument, pfe:OtherIncomeDeductionsAndCostOfSales



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value414545242121
Percentage of OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAdjustmentsBeforeTax151.9140.6204.544.430.458.3

us-gaap:DerivativeInstrumentRisk, us-gaap:DerivativeInstrumentsGainLossByHedgingRelationship, us-gaap:HedgingDesignation

us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax

us-gaap:ForeignExchangeContract, us-gaap:CashFlowHedging, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value293121565339
Percentage of OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax100.0100.0100.0100.0100.0100.0

us-gaap:ForeignExchangeContract, us-gaap:NetInvestmentHedging, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value1475243413614
Percentage of OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseBeforeAdjustmentsAndTax506.9167.7204.873.267.935.9

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012011-10-022011-07-03
Value-1272724-200-485326-291-569-734773-183875358228-181441851467-940-535-327-1308-1720-430233-137-21-584-292153-1981-130956
Percentage of OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeName

pfe:GSKConsumerHealthcare



Period End2020-03-29
Value-1600
Percentage of OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax125.8

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-01
Value0558-2680-20235-15-523-11100000000000620-171000
Percentage of OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationBeforeTax0.0100.0100.00.0100.00.0100.0100.0100.0100.0100.0100.00.00.00.00.00.00.00.00.00.00.00.0100.00.0100.00.00.00.0

us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-25215886-17271214101-34-23-62-109-2100-1-140-712852923-3-7-21971-23-3067-60-50
Percentage of OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax

us-gaap:ForeignExchangeContract, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-292019-12-312019-09-292019-03-312018-12-312018-09-30
Value384-40011223-1643
Percentage of OtherComprehensiveIncomeLossNetInvestmentHedgeGainLossBeforeReclassificationAndTax100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossNetOfTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-1490160-275-610348-859-422-613-80-1581018421449-2825678633-4-354-65635-1257-3853-320253-12141-331-205354-2403506-2621106
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012014-12-31
Value-1490160-265-613353-859-414-602-81-3849
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.096.4100.5101.4100.098.198.2101.299.9

us-gaap:NoncontrollingInterest



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value00-93-40-9-111
Percentage of OtherComprehensiveIncomeLossNetOfTax-0.00.03.3-0.5-1.1-0.02.11.8-1.2

us-gaap:Parent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value-1490160-265-613353-859-414-602-81
Percentage of OtherComprehensiveIncomeLossNetOfTax100.0100.096.4100.5101.4100.098.198.2101.2

us-gaap:StatementEquityComponents

us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCredit



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-29
Value-35-7-67-35-35-48-38-39-33-32-40-25-79-32288-29
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-29
Value-39-325-227640-489120135-52195-10501485702768256
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent111.44642.932.8-217.1-114.31018.8-315.8-346.2157.6-609.42625.0-592.0-721.5-84.423.6-882.8

us-gaap:AccumulatedGainLossNetCashFlowHedgeParent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-30
Value-364-3993-2000-81-19
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent1040.0557.1-138.8571.4-0.0168.850.0

us-gaap:AccumulatedNetUnrealizedInvestmentGainLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-29
Value-32-35717446399-1262239-426296-31787274-49
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent91.4500.0-10.4-48.6-125.7-131.2-260.530.8-187.9-746.91065.0-1184.0401.3-271.995.1169.0

us-gaap:AccumulatedOtherComprehensiveIncome



Period End2020-03-292019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-04-022016-12-312015-12-312015-09-272015-06-282015-03-292012-04-01
Value-1490-265-613353-858-414832442-2822-352-64936-1241507
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent4257.1395.51751.4-1008.61787.51089.5-2133.3-1381.27055.0445.62028.112.54279.30.0

us-gaap:AccumulatedTranslationAdjustment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-29
Value-1020566-276-471304-304-574808-159242-181387-937-522-337-1378
Percentage of OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent2914.3-8085.7411.91345.7-868.6633.31510.5-2071.8481.8-756.24532.5-348.01186.11631.2-117.04751.7

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value112211111611131551917191922-18-14165019-17617-2724123-534
Percentage of OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansBenefitPlanImprovementTaxEffect100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-03
Value-166-651-171-40-7638-57163-171-103611-1787-82-19085-144-932-418618-116-132918-88-5056113
Percentage of OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansNetUnamortizedGainLossArisingDuringPeriodBeforeTax100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-01
Value-15-97-26-11-19136-1431746327840-137-11112226-20919-69-498-247-385-15799915181589-16
Percentage of OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-01
Value-2-11-3-1-246-202215497-11-11428-264-1-631-48-2112914325-32
Percentage of OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value-66000000.0-61000000.0-60000000.0-60000000.0-60000000.0-59000000.0-60000000.0-61000000.0-62000000.0-140000000.0-140000000.0-145000000.0-163000000.0-140000000.0-140000000.0-139000000.0-139000000.0-141000000.0-140000000.0-134000000.0-136000000.0-49000000.0-48000000.0-49000000.0-49000000.0-143000000.0-137000000.0
Percentage of OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value-15000000.0-14000000.0-23000000.0-15000000.0-3000000.0-12000000.0-15000000.0-14000000.0-14000000.0-40000000.0-60000000.0-43000000.0-50000000.0-46000000.0-47000000.0-47000000.0-47000000.0-50000000.0-43000000.0-45000000.0-46000000.0-14000000.0-15000000.0-16000000.0-16000000.0-50000000.0-49000000.0
Percentage of OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeLossTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value-3776584-5925-14962173432-44-80-16325-28511636-41261-65228105-1017835-178018717673-205204-216-32-28
Percentage of OtherComprehensiveIncomeLossTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value-51-4915-740-120149-374160120384164150-492261350129-34425-200-328-533-200-15108-1568811351280-7417-36
Percentage of OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-04-03
Value-6-62-15-1520-48209371838-57404917-416-37-31-52-27-427-1635134-114-183-3
Percentage of OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherNoncashIncomeExpense



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value-12346416022623699646164-611211-141-229-24-10-142336-341655294115282152-260
Percentage of OtherNoncashIncomeExpense100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsForProceedsFromOtherInvestingActivities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value-4-6034-112-67-40-110-25-131-2979-62-13-3-330-22-37-82-206-2629339-134-220
Percentage of PaymentsForProceedsFromOtherInvestingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsOfOrdinaryDividends



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value2105199220042002204519631994203219091945182118541729172817251758163916501658166217351650152415911441
Percentage of PaymentsOfOrdinaryDividends100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsToAcquireIntangibleAssets



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value3254971091581071532738005136574228650682501126
Percentage of PaymentsToAcquireIntangibleAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsToAcquireMarketableSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value226711398429443360510117403240130829641156227231501464392735191808224611846171932858
Percentage of PaymentsToAcquireMarketableSecurities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PaymentsToAcquireShortTermInvestments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value2551225252026611402431342429138127701787348975135039848375461466015213123608721107426344497233522178
Percentage of PaymentsToAcquireShortTermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:PreferredStockDividendsIncomeStatementImpact



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-29
Value000000000000000000000001010
Percentage of PreferredStockDividendsIncomeStatementImpact0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0100.00.0100.00.0

us-gaap:ProceedsFromPaymentsForOtherFinancingActivities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value-237-69-126-46-495-35278-495-10-220-2252512717321221613182541-6284635843310
Percentage of ProceedsFromPaymentsForOtherFinancingActivities100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-04-03
Value3207-53-1156872032-644-3065-83846-2113-212117248101426-382863917-66-372310313485-1791-584
Percentage of ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value152116-26984440708135761177846433911422394124413541937150816901493145414443021468881127
Percentage of ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-012011-12-312011-04-032010-04-04
Value325714171765240036014829225564634524223587517922645513126978110702144911208813226756963868119-3843840611388
Percentage of ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ProceedsFromShortTermDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value53024873762633476091766199428146125541075682353502419985710600138913031031
Percentage of ProceedsFromShortTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0

us-gaap:ProceedsFromStockOptionsExercised



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-03-312012-04-01
Value1249155122126160625372206313732969818418779429812115842568835
Percentage of ProceedsFromStockOptionsExercised100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RepaymentsOfShortTermDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value7551429017136091766198131824932299253017811350395051007-443458144313021031
Percentage of RepaymentsOfShortTermDebt100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value172428232283184217032457200817971743231118591780170825121881174817312348172217341885320918021759162316271530180019811699207225962188223722312091218821812221
Percentage of ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RestructuringPlan

us-gaap:RestructuringAndRelatedCostIncurredCost

pfe:FocusedCompanyPlan



Period End2020-03-29
Value117
Percentage of RestructuringAndRelatedCostIncurredCost100.0

us-gaap:RestructuringCharges



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-01
Value5642383-144108141-24-928911445582404141302564694342102-3866401951509523379
Percentage of RestructuringCharges100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ConsolidationItems

us-gaap:MaterialReconcilingItems



Period End2020-03-292019-03-31
Value4110
Percentage of RestructuringCharges73.2100.0

us-gaap:ConsolidationItems, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-31
Value215610-6213
Percentage of RestructuringCharges3.636.912.043.1130.0

us-gaap:OperatingSegments, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-31
Value13102-6-9-13
Percentage of RestructuringCharges23.224.1-7.26.2-130.0

us-gaap:RestructuringCostAndReserve

pfe:AssetImpairments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-31
Value31783-992821226424971451985617
Percentage of RestructuringCharges55.418.43.66.290.034.61200.0-22.2228.653.316.73.317.642.211.614.316.7

us-gaap:EmployeeSeverance



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-31
Value2532581-165-2512-24-8-431947624183241343172
Percentage of RestructuringCharges44.676.897.6114.6-20.062.9-2400.088.9-153.642.281.880.071.551.479.173.870.6

us-gaap:OtherRestructuring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-012017-12-312017-04-022016-12-312016-04-032015-12-312015-09-272015-06-282015-03-292014-12-31
Value020-13131914-35210428304614
Percentage of RestructuringCharges0.04.7-1.2-21.530.02.31400.033.317.94.41.713.310.96.49.314.313.7

us-gaap:RestructuringReserveAcceleratedDepreciation



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value09610137121317173921145647534951242818315410274444369135
Percentage of RestructuringReserveAcceleratedDepreciation0.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:IncomeStatementLocation

us-gaap:CostOfSales



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value5667951213171739211456465245502328172952727444435833
Percentage of RestructuringReserveAcceleratedDepreciation0.066.7100.070.069.271.4100.0100.0100.0100.0100.0100.0100.0100.097.998.191.898.095.8100.094.493.596.370.6100.0100.0100.084.124.4

us-gaap:ResearchAndDevelopmentExpense



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value-5202300000000211421111129000391
Percentage of RestructuringReserveAcceleratedDepreciation0.022.20.020.023.10.00.00.00.00.00.00.00.03.62.11.98.23.94.23.65.63.21.928.40.00.00.04.367.4

us-gaap:SellingGeneralAndAdministrativeExpenses



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012015-12-312015-09-272015-06-282014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value010112000000001000811
Percentage of RestructuringReserveAcceleratedDepreciation0.011.10.010.07.728.60.00.00.00.00.00.00.00.01.00.00.00.011.68.1

us-gaap:RoyaltyIncomeNonoperating



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-02
Value1191731552318913514312196168140105
Percentage of RoyaltyIncomeNonoperating100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:SeveranceCosts1



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-31
Value2532582-166-2512-24-21-8-43-2010194763479324183241343172-511730516174136-21
Percentage of SeveranceCosts1100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation

us-gaap:CommonStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value2333526623424
Percentage of StockIssuedDuringPeriodSharesShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-01
Value6-100-7-1503
Percentage of StockIssuedDuringPeriodSharesShareBasedCompensation26.1-33.30.00.0-26.9-250.00.012.5

us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value4436412832478420926297351
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value252371136329383426930300321
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation572.7101.9106.2101.5491.0101.4100.4101.091.5

us-gaap:CommonStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value100010101
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation2.30.00.00.01.30.00.10.00.3

us-gaap:Parent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value4436412832478420926297351
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:TreasuryStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value-209-6-8-6-306-6-6-429
Percentage of StockIssuedDuringPeriodValueShareBasedCompensation-475.0-1.6-6.2-1.9-392.3-1.4-0.6-1.38.3

us-gaap:StockholdersEquityOther



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value039610-19-122-1175
Percentage of StockholdersEquityOther0.0100.0100.00.0100.0100.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:AdditionalPaidInCapital



Period End2020-03-29
Value0
Percentage of StockholdersEquityOther0.0

us-gaap:NoncontrollingInterest



Period End2020-03-292019-12-312019-09-29
Value0-161
Percentage of StockholdersEquityOther0.0-2.6100.0

us-gaap:Parent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value04000-19-122-1175
Percentage of StockholdersEquityOther0.0102.60.00.0100.0100.0100.0100.0100.0

us-gaap:RetainedEarnings



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value0000-19-122-1175
Percentage of StockholdersEquityOther0.00.00.00.0100.0100.0100.0100.0100.0

us-gaap:TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit



Period End2020-03-292019-12-312019-03-312018-12-31
Value0.0-4000000.0-131000000.0-186000000.0
Percentage of TaxCutsAndJobsActOf2017IncomeTaxExpenseBenefit0.0100.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:TreasuryStockSharesAcquired

us-gaap:TreasuryStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-04-01
Value0034018011547145
Percentage of TreasuryStockSharesAcquired0.00.0100.00.0100.0100.0100.0100.0

us-gaap:TreasuryStockValueAcquiredCostMethod



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012018-03-11
Value0000886550321105060638200
Percentage of TreasuryStockValueAcquiredCostMethod0.00.00.00.0100.0100.0100.00.0100.0100.0

us-gaap:StatementEquityComponents

us-gaap:TreasuryStock



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-01
Value000088655030110506063
Percentage of TreasuryStockValueAcquiredCostMethod0.00.00.00.0100.0100.0100.00.0100.0

us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-022017-04-022016-10-022016-07-032016-04-032015-09-272015-06-282015-03-292014-09-282014-06-292014-03-302013-09-292013-06-302013-03-312012-09-302012-07-012012-04-012011-10-022011-07-032011-07-032011-04-032010-10-032010-07-042010-04-04
Value681041101151128610089808672696475839073768775758272616140606053302640
Percentage of WeightedAverageNumberDilutedSharesOutstandingAdjustment100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation

pfe:AccruedRebates

us-gaap:OtherCurrentLiabilities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value34083285327532563344320832353039293226742261
Percentage of AccruedRebates100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinancialInstrument

pfe:AvailableforsaleSecuritiesDebtMaturitiesAfterYearFiveFairValue

us-gaap:CorporateDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value0023338541022
Percentage of AvailableforsaleSecuritiesDebtMaturitiesAfterYearFiveFairValue0.00.0100.0100.0100.0100.0100.0100.0

pfe:DebtInstrumentFairValueAdjustmentsHedgingandPurchaseAccounting



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value3570-1-5-5-4101424
Percentage of DebtInstrumentFairValueAdjustmentsHedgingandPurchaseAccounting100.0100.0100.00.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LongtermDebtType

us-gaap:UnsecuredDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-31
Value16711305161412647934791293384618729981294
Percentage of DebtInstrumentFairValueAdjustmentsHedgingandPurchaseAccounting55700.026100.023057.10.0-79300.0-9580.0-2580.0-8450.04610.06228.64158.30.0

pfe:DebtSecuritiesAccumulatedGrossUnrealizedGain



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value161110781171087729
Percentage of DebtSecuritiesAccumulatedGrossUnrealizedGain100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:DebtSecuritiesAccumulatedGrossUnrealizedLoss



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value774712193485160280139100339
Percentage of DebtSecuritiesAccumulatedGrossUnrealizedLoss100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:DebtSecuritiesAmortizedCostBasis



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value48238380591670238815169201665814705138522233720184
Percentage of DebtSecuritiesAmortizedCostBasis100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312019-01-012018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282013-12-31
Value22072099198419351946191319241875184818831838185518581952190918121859180517381794151214501477154413731554
Percentage of DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:EquitySecuritiesFVNINoncurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-31
Value1603190215301425129012231563178715571514
Percentage of EquitySecuritiesFVNINoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FairValueByMeasurementFrequency

pfe:EquitySecuritiesFVNIRestrictedNoncurrent

us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-31
Value15517623242329353242
Percentage of EquitySecuritiesFVNIRestrictedNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:HeldToMaturityCashEquivalents



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-31
Value401163217163213199237808876719
Percentage of HeldToMaturityCashEquivalents100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinancialInstrument

pfe:HeldtomaturitySecuritiesDebtMaturitiesAfterYearFiveFairValue

us-gaap:BankTimeDeposits



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value283035373935404
Percentage of HeldtomaturitySecuritiesDebtMaturitiesAfterYearFiveFairValue100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ForeignGovernmentDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value44000000
Percentage of HeldtomaturitySecuritiesDebtMaturitiesAfterYearFiveFairValue14.313.30.00.00.00.00.00.0

us-gaap:ConsolidationItems, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:StatementBusinessSegments

pfe:IntangibleAssetsNetPercentageofIntangibleAssetsNet

us-gaap:OperatingSegments, pfe:LicensingAgreementsAndOther, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-29
Value0.970.980.98
Percentage of IntangibleAssetsNetPercentageofIntangibleAssetsNet100.0100.0100.0

us-gaap:OperatingSegments, pfe:LicensingAgreementsAndOther, pfe:UpjohnSegment



Period End2020-03-292019-12-312019-09-29
Value0.010.00.0
Percentage of IntangibleAssetsNetPercentageofIntangibleAssetsNet1.00.00.0

us-gaap:ConsolidationItems, us-gaap:FiniteLivedIntangibleAssetsByMajorClass, us-gaap:Subsegments

us-gaap:MaterialReconcilingItems, pfe:LicensingAgreementsAndOther, pfe:PfizersWorldwideResearchDevelopmentAndMedical



Period End2020-03-292019-12-312019-09-29
Value0.010.010.02
Percentage of IntangibleAssetsNetPercentageofIntangibleAssetsNet1.01.02.0

us-gaap:ConsolidationItems, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass, us-gaap:StatementBusinessSegments

us-gaap:OperatingSegments, us-gaap:InProcessResearchAndDevelopment, pfe:BiopharmaSegment



Period End2020-03-292019-12-312019-09-292019-06-302019-03-31
Value0.950.950.950.860.87
Percentage of IntangibleAssetsNetPercentageofIntangibleAssetsNet97.996.996.90.00.0

us-gaap:ConsolidationItems, us-gaap:IndefiniteLivedIntangibleAssetsByMajorClass, us-gaap:Subsegments

us-gaap:MaterialReconcilingItems, us-gaap:InProcessResearchAndDevelopment, pfe:PfizersWorldwideResearchDevelopmentAndMedical



Period End2020-03-292019-12-312019-09-292019-06-302019-03-31
Value0.050.050.050.140.13
Percentage of IntangibleAssetsNetPercentageofIntangibleAssetsNet5.25.15.10.00.0

pfe:LongtermDebtCurrentMaturitiesExcludingNetFairValueAdjustmentsRelatedToHedgingAndPurchaseAccounting



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value3341458242321394473478142604267475235324201
Percentage of LongtermDebtCurrentMaturitiesExcludingNetFairValueAdjustmentsRelatedToHedgingAndPurchaseAccounting100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

pfe:LongtermInvestmentsExcludingHeldToMaturitySecuritiesAndPrivateEquityInvestments

pfe:LongtermInvestments, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value1581186315061453131712431577175415711507793
Percentage of LongtermInvestmentsExcludingHeldToMaturitySecuritiesAndPrivateEquityInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:LongtermInvestments, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value31835443245445852137784193481950965581
Percentage of LongtermInvestmentsExcludingHeldToMaturitySecuritiesAndPrivateEquityInvestments20.119.028.731.234.841.9239.6239.1306.7338.2703.8

us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency

pfe:LongtermInvestments, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value18992216193719071775176453545947639066036374
Percentage of LongtermInvestmentsExcludingHeldToMaturitySecuritiesAndPrivateEquityInvestments120.1118.9128.6131.2134.8141.9339.5339.1406.7438.2803.8

us-gaap:BalanceSheetLocation

pfe:OtherAccruals

us-gaap:OtherCurrentLiabilities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value553581617620559531641698725512509
Percentage of OtherAccruals100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:OtherTaxAssetsCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312014-12-31
Value33463344373037233598337436863582362430363050326331132791304128253127288826622566
Percentage of OtherTaxAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:PrivateEquityInvestments



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value75775674295110299441027578477408735
Percentage of PrivateEquityInvestments100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

pfe:RebatesAndDiscountsAccrual



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
Value56005700560056005500540055005396540049234300390034003300380033003000
Percentage of RebatesAndDiscountsAccrual100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation

us-gaap:AccountsReceivable



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-31
Value11071257120312261232128812971252136313521200110011001000
Percentage of RebatesAndDiscountsAccrual19.822.121.521.922.423.923.623.225.227.527.928.232.430.3

us-gaap:OtherNoncurrentLiabilities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-312014-12-312013-12-31
Value577565463472410399374406372385357272300234
Percentage of RebatesAndDiscountsAccrual10.39.98.38.47.57.46.87.56.97.88.37.08.87.1

pfe:ShorttermDebtGross



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value16042162331667110535942088477396116059009995110674
Percentage of ShorttermDebtGross100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

pfe:ShorttermInvestmentsExcludingHeldToMaturitySecurities

us-gaap:ShortTermInvestments, us-gaap:FairValueInputsLevel1, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value007151617171920161
Percentage of ShorttermInvestmentsExcludingHeldToMaturitySecurities0.00.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ShortTermInvestments, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value700273925317976687601667412452953480711749614566
Percentage of ShorttermInvestmentsExcludingHeldToMaturitySecurities0.00.075957.165106.754750.098082.473247.150178.940355.0109350.01456600.0

us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency

us-gaap:ShortTermInvestments, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value700273925324978087761669112469955380911751214567
Percentage of ShorttermInvestmentsExcludingHeldToMaturitySecurities0.00.076057.165200.054850.098182.473347.150278.940455.0109450.01456700.0

us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282013-12-312012-12-312011-12-312010-12-312009-12-31
Value527527541540538541567578597584590579588609672670649384416397444412388478374227217176
Percentage of AllowanceForDoubtfulAccountsReceivableCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:FinancialInstrument

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax

us-gaap:CorporateDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-31
Value0011102215
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax0.00.0100.0100.0100.00.0100.0100.0100.0

us-gaap:ForeignGovernmentDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-31
Value06119679561
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax0.00.01100.0900.0600.00.0450.0250.0406.7

us-gaap:FinancialInstrument

us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax

us-gaap:CorporateDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-31
Value6261217279412233
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ForeignGovernmentDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-31
Value67386717584313348
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax1116.71900.0100.058.3100.0214.845.7109.0145.5

us-gaap:USGovernmentAgenciesDebtSecurities



Period End2020-03-292019-12-312018-12-31
Value4623
Percentage of AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax66.7300.085.2

us-gaap:FinancialInstrument

us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis

us-gaap:CorporateDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-31
Value82310272140240921785905619263586955
Percentage of AvailableForSaleDebtSecuritiesAmortizedCostBasis100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ForeignGovernmentDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-31
Value2056489525383056546297548476579712616
Percentage of AvailableForSaleDebtSecuritiesAmortizedCostBasis249.8476.6118.6126.9250.8165.2136.991.2181.4

us-gaap:USGovernmentAgenciesDebtSecurities



Period End2020-03-292019-12-312018-12-31
Value30511203804
Percentage of AvailableForSaleDebtSecuritiesAmortizedCostBasis37.1109.164.4

us-gaap:FinancialInstrument

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue

us-gaap:CorporateDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value111136038238639423562557
Percentage of AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ForeignGovernmentDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value0045454494106141
Percentage of AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue0.00.012.511.811.423.94.55.5

us-gaap:USGovernmentAgenciesDebtSecurities



Period End2020-03-292019-12-31
Value285303
Percentage of AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue2590.92754.5

us-gaap:FinancialInstrument

us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue

us-gaap:CorporateDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value8071014177220131773548228902659
Percentage of AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:ForeignGovernmentDebtSecurities



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-01
Value19894863249830145406960983365527
Percentage of AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue246.5479.6141.0149.7304.9175.3288.4207.9

us-gaap:USGovernmentAgenciesDebtSecurities



Period End2020-03-292019-12-31
Value16811
Percentage of AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue2.080.0

us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-31
Value2812668742705027718015091112568220700615362
Percentage of AvailableForSaleSecuritiesDebtSecuritiesCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-31
Value2963154084304344913742416048335090
Percentage of AvailableForSaleSecuritiesDebtSecuritiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:BusinessCombinationContingentConsiderationLiability



Period End2020-03-292019-12-312018-12-31
Value669711988
Percentage of BusinessCombinationContingentConsiderationLiability100.0100.0100.0

us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent



Period End2020-03-292019-12-312018-12-31
Value124160280
Percentage of BusinessCombinationContingentConsiderationLiabilityCurrent100.0100.0100.0

us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent



Period End2020-03-292019-12-312018-12-31
Value544551708
Percentage of BusinessCombinationContingentConsiderationLiabilityNoncurrent100.0100.0100.0

us-gaap:CommercialPaper



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312014-09-282014-06-292014-03-302013-12-312012-12-31
Value1490813915129146705394731002600680040006100580000370030002700
Percentage of CommercialPaper100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.00.00.0100.0100.0100.0

us-gaap:LongtermDebtType

us-gaap:DebtInstrumentCarryingAmount

us-gaap:UnsecuredDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-31
Value347783482034602350823512232558336582870131484327833052927573
Percentage of DebtInstrumentCarryingAmount100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value3843612991171881211
Percentage of DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:LongtermDebtType

us-gaap:UnsecuredDebt



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-312015-12-31
Value173176179185189136142112122125130127
Percentage of DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet455.3409.3293.4637.92100.01236.42028.6622.21525.01041.71181.80.0

us-gaap:DebtSecuritiesAvailableForSaleAndHeldToMaturity



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012017-12-31
Value4746834059157014878716842165091443222313
Percentage of DebtSecuritiesAvailableForSaleAndHeldToMaturity100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DeferredIncomeTaxLiabilitiesNet



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012018-01-012017-12-312017-10-012017-07-022017-04-022016-12-31
Value5268557867243180359137005512574359673988390030411308793085730753
Percentage of DeferredIncomeTaxLiabilitiesNet100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DefinedBenefitPensionPlanLiabilitiesNoncurrent



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312017-10-012017-07-022017-04-022016-12-312016-10-022016-07-032016-04-032015-12-312015-09-272015-06-282015-03-292014-12-312014-09-282014-06-292014-03-302013-12-312013-09-292013-06-302013-03-312012-12-312012-09-302012-07-012012-04-012011-12-312011-10-022011-07-032011-04-032010-12-312009-12-31
Value544256385103498251255272488650065171592655315371530064065312522452646310674565296571788543644483453346357588753477337830656064846181635557345852592962016392
Percentage of DefinedBenefitPensionPlanLiabilitiesNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanTaxStatus, us-gaap:RetirementPlanType

us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear

country:US, us-gaap:NonqualifiedPlan, us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefit



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-02
Value228147197167137140160146141
Percentage of DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear100.0100.0100.0100.0100.0100.0100.0100.0100.0

country:US, us-gaap:QualifiedPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-02
Value127611111050050050010951095
Percentage of DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear559.67.55.66.0365.0357.1312.5750.0776.6

us-gaap:RetirementPlanSponsorLocation, us-gaap:RetirementPlanType

us-gaap:ForeignPlan, us-gaap:PensionPlansDefinedBenefit



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-02
Value186191191191229235229170167
Percentage of DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear81.6129.997.0114.4167.2167.9143.1116.4118.4

us-gaap:RetirementPlanType

us-gaap:OtherPostretirementBenefitPlansDefinedBenefit



Period End2020-03-292019-09-292019-06-302019-03-312018-09-302018-07-012018-04-012017-10-012017-07-02
Value155143147149149155163204199
Percentage of DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear68.097.374.689.2108.8110.7101.9139.7141.1

us-gaap:DerivativeAssets



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value1192992154211141294114010439407078221255
Percentage of DerivativeAssets100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:DerivativeInstrumentRisk, us-gaap:HedgingDesignation

us-gaap:ForeignExchangeContract, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value955591810483713654590472258179468
Percentage of DerivativeAssets80.159.652.543.455.157.456.650.236.521.837.3

us-gaap:ForeignExchangeContract, us-gaap:Nondesignated



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value8982116993855118813162162
Percentage of DerivativeAssets7.58.37.58.92.94.811.38.64.47.512.9

us-gaap:InterestRateContract, us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value148318616531543432335387418581625
Percentage of DerivativeAssets12.432.139.947.742.037.932.141.259.170.749.8

us-gaap:HedgingDesignation

us-gaap:DesignatedAsHedgingInstrument



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value110390914251015125510859258596767601093
Percentage of DerivativeAssets92.591.692.491.197.095.288.791.495.692.587.1

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:DerivativeAssetsCurrent

us-gaap:OtherCurrentAssets, us-gaap:ForeignExchangeContract, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value688413559334482477488353196234540
Percentage of DerivativeAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherCurrentAssets, us-gaap:InterestRateContract, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value15535979819788989310426
Percentage of DerivativeAssetsCurrent2.212.810.623.716.820.318.027.847.444.44.8

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementFrequency

us-gaap:OtherCurrentAssets, us-gaap:ForeignExchangeContract, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value688413559334482477488353196234540
Percentage of DerivativeAssetsCurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherCurrentAssets, us-gaap:InterestRateContract, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value15535979819788989310426
Percentage of DerivativeAssetsCurrent2.212.810.623.716.820.318.027.847.444.44.8

us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:OtherCurrentAssets, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value702465618412563574576451289337566
Percentage of DerivativeAssetsCurrent102.0112.6110.6123.4116.8120.3118.0127.8147.4144.0104.8

us-gaap:BalanceSheetLocation, us-gaap:FairValueByMeasurementFrequency

us-gaap:OtherCurrentAssets, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value702465618412563574576451289337566
Percentage of DerivativeAssetsCurrent102.0112.6110.6123.4116.8120.3118.0127.8147.4144.0104.8

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:DerivativeAssetsNoncurrent

us-gaap:OtherNoncurrentAssets, us-gaap:ForeignExchangeContract, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value35626136724926923222020092790
Percentage of DerivativeAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherNoncurrentAssets, us-gaap:InterestRateContract, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value134266557453461335246290325477599
Percentage of DerivativeAssetsNoncurrent37.6101.9151.8181.9171.4144.4111.8145.0353.36814.3665.6

us-gaap:BalanceSheetLocation, us-gaap:DerivativeInstrumentRisk, us-gaap:FairValueByMeasurementFrequency

us-gaap:OtherNoncurrentAssets, us-gaap:ForeignExchangeContract, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value35626136724926923222020092790
Percentage of DerivativeAssetsNoncurrent100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0100.0

us-gaap:OtherNoncurrentAssets, us-gaap:InterestRateContract, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value134266557453461335246290325477599
Percentage of DerivativeAssetsNoncurrent37.6101.9151.8181.9171.4144.4111.8145.0353.36814.3665.6

us-gaap:BalanceSheetLocation, us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FairValueByMeasurementFrequency

us-gaap:OtherNoncurrentAssets, us-gaap:FairValueInputsLevel2, us-gaap:FairValueMeasurementsRecurring



Period End2020-03-292019-12-312019-09-292019-06-302019-03-312018-12-312018-09-302018-07-012018-04-012017-12-312016-12-31
Value490526924702731566467489418484689
Percentage of DerivativeAssetsNoncurrent137.6201.5251.8281.9271.7244.0212.3244.5